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iZussamenfassung
Es besteht ein hoher Bedarf an einer schnellen, zuverlässigen und hochempfindlichen Bes-
timmung verschiedener Biomarker in unbehandelten physiologischen Proben im Point-of-
Care-Umfeld. Unter vielen Arten von Biosensoren scheinen elektrochemische und elektro-
nische Wandler viele Anforderungen an zukünftige Diagnosegeräte zu erfüllen, wie etwa die
marker-freie Bestimmung von Analyten in Echtzeit sowie die Möglichkeit der Massenfer-
tigung. Neuere Entwicklung der Nanomaterialien, insbesondere der Kohlenstoff-basierten
Nanomaterialien, löste auch ein Interesse an Biosensor-Anwendungen aus. In dieser Arbeit
wurden zwei Kohlenstoff-Nanomaterialien - Graphen und Kohlenstoff-Nanoröhren - ver-
wendet, um sowohl elektronische als auch elektrochemische Biosensoren zu konstruieren,
die in physiologischen Proben funktionieren können und die für den Bereich Point-of-
Care weiterentwickelt werden können. Die beiden Transduktionsarten wurden bewertet:
1) elektronisch (d. h. Feldeffekttransistor (FET)-basiert), basierend auf der Analytenbes-
timmung durch Ladung, und 2) elektrochemisch (d.h. amperometrisch), basierend auf der
Analytbestimmung durch die auftretenden Redoxreaktionen an der Elektrode. Erstens
wurden für den Aufbau eines Feld-Effekt-Transistor-Biosensors auf Basis eines Kohlen-
stoffnanoröhrchens neue und stabile Rezeptormoleküle - Nanokörper - eingesetzt und in
einem markerfreien System mit grün fluoreszierendem Protein als Modellanalyt unter-
sucht. Der Biosensor wies einen großen dynamischen Bereich mit niedriger Nachweis-
grenze auf und war Ausgangspunkt für eine weitere anwendungsorientierte Studie. Zweit-
ens wurde ein auf Graphen basierender Feldeffekttransistor (GFET) als Transducer für
den Aufbau eines TSH-spezifischen Biosensors verwendet. Diese Lösung führte zu einer
Abdeckung (und weit darüber hinaus) der TSH-Referenzwerte in physiologischen Proben.
Schließlich wurde Graphen für den elektrochemischen Nachweis unter Verwendung des
Setups aus der GFET-Studie als Arbeitselektrode verwendet. In Kombination mit dem
Enzym Flavin-Adenin-Dinukleotid-abhängiger Glucosedehydrogenase (FAD-GDH) wurde
ein elektrochemischer Glucosebiosensor hergestellt. Zusätzlich wurde ein direkter Elektro-
nentransfer vom Enzym zur Graphenelektrode beobachtet. Die Ergebnisse dieser Arbeit
tragen zur Entwicklung eines multimodalen Nachweises von Analyten in physiologischen
Proben für die weitere Anwendung im Point-of-Care-Umfeld bei.
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Abstract
There is an unmet need of fast, reliable and highly sensitive determination of different
biomarkers in untreated physiological samples in the Point-of-Care setting. Among many
types of biosensors, electrochemical and electronic transducers seem to fulfill many require-
ments for future diagnostic devices such as label-free and real-time analyte determination,
as well as a potential for mass-manufacturability. A recent advancement of nanomaterials,
with particular focus on carbon nanomaterials, triggered a foundation of a new branch
of biosensors to explore. In this work, two carbon nanomaterials - graphene and carbon
nanotubes, were used to construct both electronic and electrochemical biosensors – able to
work in physiological environment and with a potential for further development into the
Point-of-Care environment. The two types of transduction were assessed - 1) electronic
(i.e. field-effect transistor (FET) based), based on analyte determination by its charge,
and 2) electrochemical (i.e. amperometric), based on analyte determination by the redox
reactions that occur at the electrode. Firstly, for the construction of carbon nanotube
network based field-effect transistor biosensor, novel and stable receptor molecules were
employed - nanobodies, and studied in a label-free system with green fluorescent protein as
a model analyte. The biosensor exhibited a wide dynamic range with low detection limit
and triggered the next, more applicable study. Secondly, a graphene-based field-effect
transistor (GFET) was employed as a transducer for construction of thyroid-stimulating
hormone (TSH) specific biosensor. This solution resulted in coverage (and also going far
beyond) of TSH reference values in physiological samples. Finally, for the electrochemical
based detection, using the setup from GFET study, graphene was used as a working elec-
trode and in combination with the enzyme - flavin adenine dinucleotide dependent glucose
dehydrogenase (FAD-GDH), resulted in an electrochemical glucose biosensor. Direct elec-
tron transfer from the enzyme to the graphene electrode was additionally observed. The
results of this work shed light and contribute to the development of multimodal detection
of analytes in physiological samples for further application in Point-of-Care setting.
Preface
Normally, to diagnose a patient, apart from the obvious visible symptoms, the physician
takes a sample of the patient’s blood. Then, the sample is transported into centralized
laboratory, where a trained professional would analyze it to find out which biomarker
concentration (or presence) is outside the reference values of a healthy individual. A
biomarker is a naturally occuring indicator (gene, protein etc.) that can help assess the
presence and progression of disease. Among biomarkers, proteins are especially useful
due to their abundance in body fluids. As for selectively targeting the proteins even in
complex samples, antibodies can be used. Another class of biomarkers are metabolites
such as glucose or lactate that can be more or less specific to the disease. Once the illness
is diagnosed (e.g. sepsis diagnosis by means of lactate determination), they can help
monitor its progression and trigger immediate measures to overcome the disease symptoms
(glucose monitoring and insulin dosing in diabetes). Analyzing the sample in a centralized
analytical laboratory can take from several hours even up to a few days and in case of
some very fast progressing diseases, it can be already too late for the patient’s health and
well-being. Therefore, near-patient testing, e.g. at the doctor’s office (at Point-of-Care)
and a result within the time of medical checkup, is needed. Unfortunately, so far the need
for fast and reliable, on-the-spot diagnosis in the Point-of-Care setting is not completely
realized. Huge diagnostics companies (e.g. Roche) are trying to make the dream of a
simple, reliable and fast diagnostics device that can be used at the Point-of-Care, come
true. Biosensors, devices comprising of a biomolecule sensitive layer - receptor, and a
transducer that translates the biological signal generated at the receptor into measurable
quantity, pose a very promising solution. A first biosensor appeared as early as 19621 and
a completely new era of diagnostics began.
Among many types of biosensors, the main research focused on only three types -
optical, electronic and electrochemical (see Section 1.1). Although optical methods have
been used in biology/biochemistry for a long time (e.g. one of the first radioimmunoassays
- 19602), due to laborous sample preparation and complex instrumentation needed, they
are not the first choice for Point-of-Care diagnostics. The greatest potential for devel-
opment is attributed to electrochemical and electronic biosensors. A huge advancement
of nanomaterial research in the last 30 years (3,4) accelerated the biosensors industry.
Nanomaterials posses very high surface-to-volume ratio, not only do they enhance the
surface area of the devices, but can also increase the sensitivity, time of response and be
a building block for miniaturization of devices.
In this work two different carbon nanomaterials: graphene and carbon nanotubes
are used in order construct sensitive, reliable and fast biosensing devices that work in
physiological buffer conditions accurately and specifically determining the concentration
of given analyte. The goal of this thesis is to show the applicability and versatility of
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novel carbon nanomaterials in different aspects of biosensing, due to high sensitivity and
stability.
First, semiconducting single-walled carbon nanotube network based field-effect tran-
sistors were used as transducers for a green-fluorescent protein (GFP) specific nanobody-
based biosensor (see Chapter 2). In the field of FET-based biosensors in complex matri-
ces (serum, blood, plasma etc.), one encounters two large challenges: a) Debye screening,
which is caused by the high concentration of ions that for a double layer on the liquid/solid
interface and b) the non-specific adsorption of different species (proteins, cells, etc.). The
idea pursued in this Chapter is based on co-immobilization of: 1) very short and stable
receptors - nanobodies (VHH), that bring the specific analyte binding event closer to
the biosensor’s surface and provide high density of receptors and 2) poly(ethylene glycol)
(PEG), that is shown to reduce the Debye screening limitation5–7 and at the same time,
prevents the non-specific adsorption.7–9 The resulting biosensors show high selectivity,
sub-picomolar detection limit and a dynamic range exceeding 5 orders of magnitude in
physiological solutions.
In the later part of the work, graphene was shown to be effective both as a FET channel
in electronic-based biosensing and as a working electrode in electrochemical-based biosens-
ing. The construction and application of thyroid-stimulating hormone (TSH) specific
graphene FET-based biosensor is presented in the Chapter 3. Here, the receptors (TSH
specific F(ab’)2 antibody fragments) were co-immobilized with PEG to enable biosensing
in high ionic strength buffer and reduce non-specific adsorption. The biosensor exhibited
selective detection of TSH with concentrations as low as 10 fM, with a dynamic range
spanning several orders of magnitude (i.e. fM – nM). By careful analysis of the changes
in electronic properties upon analyte binding, the work presented in this chapter helps
elucidating the mechanism of biosensing using a graphene field-effect transistor.
The third major part of the work describes the development of amperometric glucose
biosensor with single-sheet graphene as a working electrode (Chapter 4). Interestingly, the
glucose specific enzyme used (here, flavin adenine dinucleotide (FAD) dependent glucose
dehydrogenase, FAD-GDH) exhibits direct electron transfer to the graphene electrode
making it a 3rd generation amperometric glucose biosensor. To verify the activity of
the enzyme, a "classical" redox mediator was used - ferrocenemethanol. Additionally,
in order to reduce electrochemical intereferences, a novel and unexplored redox mediator
(nitrosoaniline derivative, NA) was employed.
v”You cannot hope to build a better world without improving
the individuals. To that end, each of us must work for our own
improvement and, at the same time, share a general responsibility
for all humanity, our particular duty being to aid those to whom
we think we can be most useful.”
„Nie można bowiem mieć nadziei na skierowanie świata ku
lepszym drogom, o ile się jednostek nie skieruje ku lepszemu.
W tym celu każdy z nas powinien pracować nad udoskonaleniem
się własnym, jednocześnie zdając sobie sprawę ze swej, osobis-
tej odpowiedzialności za całokształt tego, co się dzieje w świecie,
i z tego, że obowiązkiem bezpośrednim każdego z nas jest dopoma-
gać tym, którym możemy się stać najbardziej użyteczni.”
— Maria Skłodowska-Curie
Dedicated to my wonderful son - Jan Henryk.
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1 | Introduction
1.1 Biosensors - receptors
A biosensor is an analytical device comprising a bioreceptor (biological recognizing
element) from different classes (enzymes, antibodies and its fragments, whole cells, DNA,
RNA etc.) and a transducer (physicochemical signal detection element), which can
be divided into several subgroups: 1) electrochemical (including amperometric and po-
tentiometric), 2) electrical (field-effect transistor based and conductometric), 3) optical,
4) calorimetric and 5) piezoelectric (quartz crystal microbalance, cantilever)10 (see Fig.
1.1. Biosensors offer a lot of advantages over conventional analytical techniques, includ-
ing portability, miniaturization and on-site monitoring as well as good selectivity and
sensitivity depending on the transducer.
In this work, carbon nanomaterial based electrochemical (in particular graphene based,
Chapter 4) and electrical (carbon nanotube based - Chapter 2 and graphene based -
Chapter 3) biosensors were explored. In this section, the fundamentals of biosensing
methods will be described.
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Figure 1.1 – Scheme of a biosensor. Biological sensing elements are coupled to transducers.
These traduce the signal to deliver a readable output.
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1.1.1 Immunosensors (immunochemical biosensors)
Immunosensing, as the name suggests, is the field of biosensing focusing on sensing the
analytes via the immunochemical reactions. An antibody (or one of its many fragments,
see Fig. 1.3) is immobilized on the surface of the transducer and the analyte binding
signal is recorded as a function of the analyte concentration (see Fig. 1.2). This strategy
is called "label-free" or "direct assay" and is the least complex when it comes to the
mechanism, yet most difficult to utilize, because of rather small signals generated and
high abundance of non-specific signal. Often, a control biosensor is additionally used,
which generates the signal from binding of the non-target species (interferences) and after
the subtraction of "active" and "control" biosensor signals, target binding specific signal
can be assessed. In order to enhance the signal and increase the specificity of the assay,
researchers use "labels" - a species, most commonly a secondary antibody, that binds
to the already bound analyte. "Labels" can include a bioconjugated (attached to the
secondary antibody) element like an enzyme (e.g. horseradish peroxidase), that catalyses
a redox reaction, the product of which can be sensed e.g. electrochemically.11
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Figure 1.2 – Schematic representation of the main components and mode of action of a
immunosensor. In this case, a typical label-free immunoassay-based biosensor is depicted as
an example of a biosensor setup. A device capable of immobilizing the molecule of interest
for detection will allow the conversion of an input signal to a quantifiable output signal for
transduction and generation of a final measurement.
Antibodies (immunoglobulins - IgG) are a large family of Y-shaped glycoproteins,
which are used by the immune system as recognition elements for different targets (anti-
gens) in order to neutralize pathogens (bacteria, viruses, etc.). Each tip of the "Y" of an
antibody contains a paratope ("lock") that is specific for one particular epitope ("key") on
an antigen, allowing these two structures to bind. Their structures are divided into two
regions - the variable (V) region (top of the Y) defining antigen binding properties and
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the constant (C) region (stem of the Y), interacting with effector cells and molecules.12
IgGs contain two identical heavy (H, 50 kDa, Fig. 1.3, blue) and two identical light (L,
25 kDa, Fig. 1.3, green) chains (resulting in a molecular weight M w ≈ 150 kDa). Several
disulfide bonds link the two heavy chains (black lines between blue chains in IgG, Fig.
1.3), the heavy and light chains, and reside inside the chains. The variable (V) regions of
both chains cover approximately the first 110 amino acids, forming two antigen-binding
(Fab) regions (55 kDa each), whereas the remaining sequences are constant (C) regions,
forming Fc (fragment crystallizable) regions for effector recognition and binding. Two
Fab fragments linked with a disulfide bridge form a F(ab’)2 fragment used in the work
described in Chapter 3. The sequences of both the heavy and light chains vary greatly
between different antibodies. Approximately 95% are constant and the remaining 5% are
variable and create their antigen-binding specificity.12 A special type of immune system
entity - nanobodies - a variable region of a heavy chain of a camelid antibody exist in
camelids (e.g. alpacas) and has a very small size of around 15 kDa. Those were used and
are further described in Chapter 2.
Figure 1.3 – Schematic representation of different antibody formats, showing intact "classic"
IgG molecules alongside camelid VhH-Ig and shark Ig-NAR immunoglobulins. Camelid VhH-
Ig and shark Ig-NARs are unusual immunoglobulin-like structures comprising a homodimeric
pair of two chains of V-like and C-like domains (neither has a light chain), in which the
displayed V domains bind target independently. Shark Ig NARs comprise a homodimer of
one variable domain (V-NAR) and five C-like constant domains (C-NAR). A variety of
antibody fragments are depicted, including Fab, scFv, single-domain VH, VhH and V-NAR
and multimeric formats, such as minibodies, bis-scFv, diabodies, triabodies, tetrabodies and
chemically conjugated Fab‘ multimers (sizes given in kilodaltons are approximate). Circled
receptors were used in this work - VHH in Chapter 2 and F(ab’)2 in Chapter 3. Reprinted
and readapted with permission from.13 Copyright 2005 Nature Publishing Group.
Historically, antibodies were first used as receptors in immunosensors, but due to their
size and (in)stability, researchers began to look for alternatives. With advances in protein
engineering and biochemistry, new classes of receptors emerged: from different antibody
fragments (Fig. 1.3), through aptamers (RNA or DNA based receptors) to molecularly
imprinted polymers (polymers with a molecular imprint of the target analyte).
Among such short receptors are single-domain antibodies (so-called nanobodies). With
a molecular weight of only ∼13 kDa and size of ∼2-3 nm, nanobodies are much smaller
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than the common whole antibodies (∼150 kDa, ∼15 nm) or Fab fragments (∼50 kDa,
7- 8 nm).14,15 In addition, the nanobodies are easily produced, highly soluble and stable
in a range of different conditions.16 So far, their usefulness as recognition elements of a
biosensor has been proven in photoelectrochemical17,18 and electrochemical19,20 formats,
but not in combination with transistor-based sensors.
All immunochemical reactions are governed by a receptor specific constant - the dis-
sociation constant (K d),21 which measures the tendency of a receptor-antigen complex to
separate (dissociate) reversibly into free receptor and free antigen.
Binding of the antigen (A) to the receptor (R):
A+R
kon

koff
A−R (1.1)
is described by the law of mass action, applying the association constant K a:
Ka =
kon
koff
=
[A−R]
[A]× [R] (1.2)
or its reciprocal value, the dissociation constant (more commonly used) K d:
Kd =
1
Ka
=
koff
kon
=
[A]× [R]
[A−R] (1.3)
Association constants possess the dimension of reciprocal concentration (M−1) and
higher values indicate stronger binding, while dissociation constants possess the dimen-
sion of a concentration (M) and lower values indicate stronger binding.
1.1.2 Enzymatic biosensors
The first (enzymatic) biosensor ever was developed by Clark1 in as early as 1962. The idea
was quite simple: a cell containing a platinum and silver electrode was used. Platinum
acts as a oxygen reduction electrocatalyst, while the silver electrode is a pseudo-reference
electrode. Upon applied potential between the two electrodes, the oxygen from the solu-
tion is electroreduced at the Pt electrode. This setup, after implementing an additional
layer of glucose oxidase, which catalyses the oxidation of glucose while locally using up
oxygen, was used as a first ever biosensor. The rate of reaction current is limited by the
diffusion of both glucose and oxygen.
Given the above, an enzymatic biosensor is a device that uses the enzyme to provide
selectivity of the method (e.g. amperometry like in the example above1) by catalyzing
a specific biochemical reaction. The selectivity of the enzymatic biosensor towards the
analyte is given by the selectivity of the enzyme itself. The analyte in the context of
catalysed reaction can play different roles - substrate (e.g. glucose biosensors22), inhibitor
(organopesticide biosensor based on inhibition of acetylcholinesterase e.g.23) or even the
enzyme itself (lactate dehydrogenase activity biosensor e.g.24)
Enzyme basics Enzymes are the biological systems catalysts - proteins that are able
change the pathway and thus lower the activation energy of a reaction. The specificity
of an enzyme is due to the precise interaction of the substrate with the enzyme. This
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precision is a result of the intricate three-dimensional structure of the enzyme protein.
Catalysis takes place at a particular site on the enzyme called the active site. The catalytic
activity of many enzymes depends on the presence of small molecules termed cofactors,
which can be covalently bound to the enzyme (e.g. FAD in glucose dehydrogenase25) or
free-diffusing in the solution (as in the case of NAD+-dependent lactate dehydrogenase26).
Such an enzyme without its cofactor is referred to as an apoenzyme, whereas the complete,
catalytically active enzyme is called a holoenzyme.27 There are many classes of enzymes,
but the ones that are mostly used in biosensors, belong to the class of oxido-reductases
(Enzyme Commission number - EC 128), which as the name suggests catalyse oxidation-
reduction reactions.
The catalytic activity of an enzyme is the property measured by the increase in the
rate of reaction of a specified chemical reaction that the enzyme produces in a specific
assay system. Enzyme activity is defined as moles of substrate converted per unit time.
The SI unit for enzyme activity is katal, although more commonly used one is an enzyme
unit (U), which is 1 µmol/min (1 U = 16.67 nkat).29 Another commonly used measure
to describe enzyme activity is specific enzyme activity. It gives information about the
enzyme sample purity and is expressed as activity of an enzyme per milligram of total
protein (unit: µmol
min×mg or simply U/mg).
The primary function of enzymes is to enhance rates of reactions, so that they are
compatible with the needs of the organism. The most commonly used kinetic model
was developed by Michaelis and Menten30 (see 1.4). At a fixed concentration of enzyme,
reaction rate (V 0) is almost linearly proportional to substrate concentration [S] when
[S] is small, but is nearly independent of [S], when [S] is large. The critical feature in
the Michaelis-Menten model is that a specific E-S complex is a necessary intermediate
in catalysis. Considering an enzyme (E) that catalyses the reaction of substrate (S) to
product (P) conversion:
E + S
k1

k−1
E − S k2−→E + P (1.4)
where k−1 is the forward rate constant, k−1 is the reverse rate constant and k 2 is the
catalytic rate constant.
Assuming that the enzyme concentration [E] is much smaller than the substrate con-
centration [S], the rate of product formation V 0 is given by equation:
V0 =
d[P ]
dt
= Vmax
[S]
KM + [S]
= kcat[E]0
[S]
KM + [S]
(1.5)
where KM is the Michaelis-Menten constant, k cat is the turnover number - maximum
number of substrate molecules converted to product per enzyme molecule per second, E 0
is the initial enzyme concentration.
The reaction order depends on the relative size of the two terms in the denominator.
At low substrate concentration [S] KM the equation 1.5 simplifies to:
V0 = kcat[E]0
[S]
KM
(1.6)
Under these conditions the reaction rate increases linearly with substrate concentration
[S] (first order kinetics).
8 CHAPTER 1. INTRODUCTION
With higher substrate concentration - [S]  KM , the reaction rate becomes sub-
strate concentration independent (zero order kinetics) and asymptotically approaches the
maximum reaction rate (saturates) - Vmax = kcat[E]0.
Figure 1.4 – Michael-Menten kinetics A A plot of the reaction velocity (V0) as a function
of the substrate concentration [S] for an enzyme that obeys Michaelis-Menten kinetics shows
that the maximal velocity (Vmax) is approached asymptotically. The Michaelis constant (KM )
is the substrate concentration yielding a velocity of V max/2. B Concentration profiles of
substrate [S], product [P], free enzyme [E] and enzyme-substrate complex [E-S] according to
Michaelis-Menten kinetics.
Practically, Michaelis-Menten constant is the concentration at which the reaction rate
is half of the maximum. Furthermore, the Michaelis-Menten constant is often used as mea-
sure of substrate’s affinity of the enzyme - the smaller the KM , the higher the substrate’s
affinity towards the enzyme. KM has a direct influence on the analytical parameters of
different enzymatic biosensors - the reaction rate can be easily subsituted by biosensor’s
signal (be it electrochemical, optical etc.). For example, for glucose dehydrogenase,31 the
KM is 68 mM, which makes a biosensor’s steady-state response linear in the relevant
reference range in blood (1 - 20 mM), but for lactate oxidase, the KM is about 1 mM32
and with the reference range 0.2 - 25 mM (extreme case - sportsmen),33 the measurement
needs to be finely timed to resolve the higher lactate concentrations. KM depends on
substrate and enzyme pair, as well as on pH and temperature.34
1.1.3 Receptor immobilization
In order to construct a biosensor, the receptor needs to be immobilized on the sensing sur-
face (transducer). There are several strategies for receptor immobilization 1) adsorption,
2) covalent bonding, 3) entrapment in a matrix, 4) cross-linking (with e.g. glutaralde-
hyde) and 5) affinity based binding.35 Each immobilization method presents advantages
and drawbacks. The choice of the most appropriate technique depends on the receptor
nature, the transducer and the associated detection mode. A perfect immobilization strat-
egy aims at preserving the activity of the receptor, stability, maximizing the biosensor’s
response (sensitivity) and reproducibility.
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Pyrene chemistry Covalent bonding of receptor to a linker molecule (pyrene deriva-
tives) is used to fabricate a specific target carbon nanomaterial based biosensor. Generally,
the bare CNT or bare graphene are first exposed to the linker molecules (pyrene deriva-
tives) to introduce the anchoring sites (carboxyl groups -COOH, N -hydroxysuccinimide
(NHS) ester of carboxyl groups or maleimide groups (MAL)) for the later receptor and
spacer immobiliziation. Pyrene (C16H10) is a polycyclic aromatic hydrocarbon consisting
of four fused benzene rings, resulting in a flat aromatic system. The pyrenes form a mono-
layer on the surface of both graphene and carbon nanotubes by means of pi-pi stacking.36,37
Three types of pyrene (Fig. 1.5 A) derivatives were used in this work: 1-pyrenebutyric
acid (PBA, Fig. 1.5 B), 1-pyrenebutyric acid N -hydroxysuccinimide ester (PBA-NHS,
Fig. 1.5 C) and N -(1-pyrenyl)maleimide (py-MAL, Fig. 1.5 D).
Figure 1.5 – Chemical formulas of pyrene and its derivatives used in this work. A Pyrene,
B 1-pyrenebutyric acid, C 1-pyrenebutyric acid N-hydroxysuccinimide ester and D N-(1-
pyrenyl)maleimide
EDC/NHS chemistry One of the most standard, specific and widely used bioconju-
gation methods is based on carbodiimides.38,39 Carbodiimide conjugation works by ac-
tivating carboxyl groups (-COOH) for direct reaction with primary amines (-NH2) via
amide bond formation. Because no portion of their chemical structure becomes part of
the final bond between conjugated molecules, carbodiimides are considered zero-length
carboxyl-to-amine crosslinkers.40 The most widely used carbodiimide is water soluble (but
also easily hydrolyzed!) 1-ethyl-3-(-3-dimethylaminopropyl) carbodiimide hydrochloride
(EDC). It reacts with carboxylic acid groups to form an active O-acylisourea intermediate
that is easily displaced by nucleophilic attack from primary amino groups in the reaction
mixture (e.g. -NH2 residues of surface lysines present in the antibody or an enzyme).
The primary amine forms an amide bond with the original carboxyl group, and an EDC
by-product is released as a soluble urea derivative. N -hydroxysuccinimide (NHS) is often
included in EDC coupling protocols to improve efficiency or create stable in dry conditions
(amine-reactive) intermediates. EDC couples NHS to carboxyls, forming an NHS ester
that is considerably more stable than the O-acylisourea intermediate while allowing for
efficient conjugation to primary amines at physiologic pH. For a simplified mechanism of
EDC/NHS conjugation see Fig. 1.6 A. NHS activated linkers are also available to simply
introduce the protein of interest to the desired surface.
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Maleimide chemistry The often occuring -SH surface groups (cysteine residues) can
be conjugated to via the sulfhydryl-reactive crosslinker reactive groups like maleimide.
There are many advantages of using this conjugation (immobilization) strategy:
1. Thiols are present in most proteins but are not as numerous as primary amines,
thus crosslinking via thiol groups is more precise and selective.
2. Thiol groups in proteins are often involved in disulfide bonds, so cross-linking at
these sites typically does not significantly modify the underlying protein structure
or block binding sites.
3. The number of available thiol groups can be easily controlled or modified (reduction
of disulfide bonds or introduction of thiol groups into molecules).
The maleimide group reacts specifically with sulfhydryl groups resulting in formation of
a stable, irreversible thioether linkage. For a simplified mechanism of maleimide/thiol
conjugation see Fig. 1.6 B.
Figure 1.6 – A Carboxyl-to-amine crosslinking using the carbodiimide EDC and NHS. B
Maleimide reaction scheme for chemical conjugation to a thiol.
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1.2 Biosensors - transducers and analytical methods
1.2.1 Electrochemical methods
Electrochemistry studies reactions with electron transfer at the electrolyte|electrode in-
terface. The electron transfer is caused by oxidation-reduction reactions. Figure 1.7
compares: A homogeneous (one phase - liquid) electron transfer (reduction reaction)
from cobalt cyclopentadienyl (Co(Cp · )2)) to ferrocenium ion (Fc
+) Fc+ + [Co(Cp · )2] 

Fc+ [Co(Cp · )2]
+ (Fc+ reduction coupled with Co(Cp · )2 oxidation) with B heterogeneous
(on the liquid|solid interface) electron transfer from the electrode to Fc+ (ferrocenium ion
electroreduction). In the beginning of the process shown in the Fig. 1.7 B, the electron
potential is not sufficient to be transferred from the electrode, but when the electron po-
tential is increased to a certain level higher than the lowest unoccupied molecular orbital
(LUMO) energy level of the Fc+, the electron can be transferred from the electrode to
Fc+ thus reducing the Fc+ ion to Fc.
Figure 1.7 – (A) Homogeneous and (B) heterogeneous reduction of Fc+ to Fc. The po-
tential of the electrons in the electrode is controlled by the potentiostat; their potential can
be increased until electron transfer becomes favorable. Reprinted with permission from.41
Copyright 2018 American Chemical Society.
A typical electrochemical cell consists of 3 different electrodes: 1) a stationary working
electrode (WE), 2) a reference electrode (RE) which the potential is applied against, and 3)
a counter (auxiliary) electrode that completes an electrical circuit with WE over which the
current flows. All three are immersed in a stagnant solution containing the electroactive
species as well as an excess of supporting electrolyte (an inert salt, e.g. KCl) to provide
sufficient ionic conductivity and migration. The electrochemical reaction under study
takes place at the surface of the working electrode. The electrochemical signal recorded
reflects the process taking place at the working electrode such that our interest is focused
on the interface of this electrode with the electrolytic solution.
Mass transport When the sufficient potential is applied, the electroactive species in
the solution, undergo redox reaction at the electrode changing the local concentration of
the respective species in the vicinity of the electrode. This potential is generally governed
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by the Nernst equation, which predicts the relationship between concentration and voltage
(potential difference).
E = E0 +
RT
nF
ln
Fc+
Fc
(1.7)
In a typical electrochemical experiment, a large amount of electroactive molecules are
involved and thus the diffusion process obey the Fick’s laws accounting for changes in
concentration with time and distance from the working electrode.42 For the simplest case
of planar electrode exhibiting linear diffusion, all the points at a given distance from the
electrode surface in the perpendicular coordinate x are equivalent such that net flux of
molecules only occurs in this direction. According to Fick’s first law, the flux, j (unit:
mol
m2 × s), at a given point x 1, is proportional to the concentration gradient:
jj,x1 = −Dj(
∂cj
∂x
)x1 (1.8)
where D j is the diffusion coefficient of species j. The solutions of the Equation 1.8 (i.e.
the concentration profiles of the participating species) are functions of only two indepen-
dent variables: time t and the distance to the electrode surface in the x coordinate.42
As mentioned, during the time of the measurement, the concentration gradient can
change and this is described by the Fick’s second law of diffusion:
∂cj
∂t
= −Dj(∂
2cj
∂x2
) (1.9)
Fick’s second law predicts the variation of concentration of different species as a func-
tion of time within the electrochemical cell. In order to solve these equations analytical
or computational models are usually used. Concentration profiles are the graphical rep-
resentations of the Fick’s second law solutions (equations) and they indicate the gradual
expansion of the diffusion layer towards the bulk of the solution as shown in the Fig. 1.8
A-G.
Cyclic voltammetry
Cyclic voltammetry is the basic and the most informative electroanalytical technique
provides information about i.e. the potentials of redox processes, the oxidation state of
the redox species, the number of electrons involved, the rate of electron transfer, possible
chemical processes associated with the electron transfer, adsorption effects, standard redox
potential (E0 =
Ep,c+Ep,a
2
) or transfer electron number (∆E = Ep,a − Ep,c = 58/n), where
E 0 is the standard redox potential, E p,a is the anodic (oxidation) peak potential, E p,c is
cathodic (reduction) peak potential and n - number of electrons.
Considering a simple solution containing 1 mM ferrocene (Fc), the concentration of
its oxidized form at the beginning of the experiment is 0 (Fig. 1.8 A). When a potential
between WE and RE is linearly increased from E 1 to E 1, the electrooxidation reaction
of Fc starts to occur, which is seen as the increase of the current (Fig. 1.8 H) and
consequently, the concentration of Fc in the vicinity of the electrode drops (Fig. 1.8
B). Here, the electron transfer rate is fast in comparison to the voltage sweep rate and
thus at the electrode surface an equilibrium is established identical to that predicted by
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thermodynamics (Nernst equation). The rate of the reaction reaches its maximum (Fig.
1.8 C) exhibiting a characteristic current peak (I p,a - anodic (oxidation) peak) at the
potential E = E p,a. The peak occurs, since the diffusion layer has grown sufficiently
above the electrode that the flux of the electroactive species to the electrode is not fast
enough to satisfy the requirements of the Nernst equation. In this situation the current
begins to drop. At this point, the concentration of Fc near the electrode is approaching
0 and finally reaches 0 with further potential increase (Fig. 1.8 D). The the diffusion
layer continues to grow throughout the scan (see Section 1.2.1). This slows down mass
transport of Fc to the electrode. Typically then, the potential scan direction is reversed
and the Fc+ reduction reaction is starting to appear in the current response (Fig. 1.8 E).
The maximum for cathodic (reduction) current is then achieved (I p,c at the potential E =
E p,c) with the maximum reaction rate in the F point (Fig. 1.8 F). After that with further
scanning, the reduction current decreases to reach the G point, similarly extending the
diffusion layer as with the "forward" scan (Fig. 1.8 G).
Figure 1.8 – A-G Concentration profiles (mM) for Fc (blue) and Fc+ (green) as a function
of the distance from the electrode (d, from the electrode surface to the bulk solution, e.g.
0.5 mm) at various points during the voltammogram. H Voltammogram of the reversible
reduction of a 1 mM Fc solution to Fc+, at a scan rate of 100 mV/s. I Applied potential as
a function of time for a generic cyclic voltammetry experiment, with the initial, switching,
and end potentials represented (A, D, and G, respectively). Reprinted and adapted to comply
with IUPAC convention with permission from.41 Copyright 2018 American Chemical Society.
In equilibrium between the Fc/Fc+, the potential in an electrochemical cell is described
by the Nernst equation:
E = E0 +
RT
nF
ln
(Ox)
(Red)
= E0 + 2.3026
RT
nF
log10
(Ox)
(Red)
(1.10)
where E 0 is the standard potential, F is Faraday’s constant, R is the universal gas con-
stant, n is the number of electrons, T is the temperature and (Ox) and (Red) are the
activities of oxidized and reduced form of a species, respectively.
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The magnitude of the peak current for a reversible electron transfer is given by the
Randles-Ševčik equation 1.11:43
Ip = 0.446nFAC
√
nFvD
RT
(1.11)
where I - peak current, n - number of electrons transferred per molecule diffusing to the
electrode surface, F - Faraday constant, A - electroactive surface area, C - concentration
of the analyte in solution, v - scan rate, D - diffusion coefficient of the analyte, R - gas
constant and T - absolute temperature.
The Randles-Ševčik equation describes the effect of scan rate on the peak current -
with an increase of the scan rate, the peak current also increases.44 The equation is used
variously e.g. to estimate the diffusion coefficient D of redox species.44 Additionally, for
a known diffusion coefficient and concentration of electroactive species, the electroactive
surface area of the working electrode under study using this equation (applied in Section
4.2.2) and used for comparisons with the literature. Moreover, plotting of I p vs. v1/2 pro-
vides information about stoichiometry of the redox process e.g. for a chemically reversible
redox process, the function I p in terms of v1/2 is linear.
Chronoamperometry
Another commonly used electrochemical technique for analysis is chronoamperometry,
where a step of potential is applied and kept constant while the current response is
measured in undisturbed conditions (I = f(t)), i.e. the mass transport is diffusion limited.
The potential is stepped from E 1, where no current flows, i.e. the oxidation or reduction of
the electrochemically active species does not take place, to E 2 where the current belongs
to the electrode reaction is limited by diffusion (see Fig. 1.9).
Figure 1.9 – Typical waveform of the potential step (A) and the respective chronoampero-
metric response (B). (Ic - capacitive current, Id - diffusion current).
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The Faradaic current response decays as described in the Cottrell equation:45
I = nFAC
D
pit
(1.12)
where I - current, n - number of electrons transferred per molecule diffusing to the
electrode surface.
The equation shows that the current decays (as shown in Fig. 1.9 B), from an initial
infinite value, proportionally as /
√
t and, furthermore, that no steady state current is ever
achieved. The capacitive current, I c, coming from the electrical double layer formation,
is also present in the beginning of the experiment, but decays exponentially (as shown in
Fig. 1.9 B). Plotting I (t) vs. t−1/2 and reading out the slope can give information about
diffusion coefficient. Finally, the Cottrell equation can be applied only when considering
planar working electrodes of "infinite" size (the edge effect is negligible).43
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1.2.2 Field-effect transistor based biosensors
Field-effect transistor-based transducers are considered charge-sensitive devices and ex-
hibit a range of advantages such as excellent sensitivity and selectivity, label-free detection,
real-time response, cost-effective fabrication, and ease of miniaturization and integration
in electronic chips. This makes FET-based biosensors applicable in Point-of-Care set-
ting.46
The operating mechanism of a field-effect transistor is shown using the example of the
metal oxide semiconductor FET (MOSFET) (see Fig. 1.10).
Figure 1.10 – A Scheme of a typical n-channel MOSFET. The p-type semiconductor sub-
strate (bulk) contains two n-doped regions (source and drain). A metal gate is placed on top
of the semiconductor, isolated by a metal oxide. B When a positive voltage VG between gate
and source is applied, electrons are pulled from the bulk to the semiconductor/oxide interface
thus creating an inversion channel. C If a positive voltage VSD is applied between source and
drain, electrons in the channel will migrate to the drain. The channel is narrowed by VSD
close to the drain. D Transfer curve of the n-type MOSFET (ISD vs. VG) plotted in ISD
linear scale. The current is linearly depends on VG above the threshold voltage Vth. There,
the slope is called the transconductance gm. Below the threshold voltage Vth, the current de-
pends exponentially on the gate voltage VG. E Transfer curve of the n-type MOSFET (ISD
vs. VG) plotted in ISD semi-logarithmic scale. The exponential function is a straight line on
a semi-log plot up to the threshold voltage Vth. The reciprocal slope of that function is called
the subthreshold swing S.
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The substrate is a p-type semiconductor, containing two n-doped regions acting as
source and drain terminals. A metal gate is placed on top of the semiconductor isolated
by a metal oxide. The doped regions are isolated from the substrate by p-n junctions.
When a positive voltage is applied to the gate terminal, negative charge carriers (electrons)
are attracted to the semiconductor/oxide interface thus creating an inversion layer (Fig.
1.10 B). If no current flows at V SD = 0, the transistor is called "enhancement type" or
"normally-off". When additionally a positive source-drain voltage V SD is applied, the
current I SD starts to flow between the two terminals (Fig. 1.10 C).
The source-drain current I SD through the channel is described by equation:
ISD = µCox
W
L
QVSD = µCox
W
L
(VG − Vth)VSD (1.13)
where µ - charge mobility, C ox - capacitance of the gate oxide per area, W - channel
width, L - channel length, Q - charge density in the channel, V SD - source-drain voltage,
V G - gate voltage and V th - threshold voltage.
The consequence of the above equation is that if the gate voltage is much lesser than
the threshold voltage V G  V th, there is no current flowing between the source and drain
I SD.
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Surface charge and surface potential The immersion of some materials in electrolyte
solution causes the surface charge to appear by dissociation of surface sites, adsorption
of ions from solution, crystal lattice defects or an imbalance in number of lattice ions on
the surface of a ionic crystal. Surface charges are the cause of an electric field attracting
counter ions. According to the simplest model, the layer of surface charges and counter
ions, which neutralize the surface charges, is called "electric double layer" or "Helmholtz
layer" (see Fig. 1.11 A).47 Here, the surface potential linearly dissipates from the surface
to counter-ions. In a more advanced model by Gouy and Chapman, thermal fluctuations
tend to drive the counterions away from the surface, which in consequence leads to the
formation of a "diffuse double layer" (see Fig. 1.11 B).
The Stern’s model (see Fig. 1.11 C) combines the Helmholtz model with the Gouy–
Chapman model to explicitly account for the two different regions of charge – namely
the Stern layer and the diffuse layer. Inside the Stern layer, one can discriminate two
Helmholtz planes: inner (IHP), where the counter ions specifically adsorb on the interface,
and outer (OHP) which is located on the plane of the centers of the next layer of non-
specifically adsorbed ions. The diffuse layer, begins at the outer Helmholtz plane.
Figure 1.11 – Schematic representations of EDL structures according to the A Helmholtz
model, B the Gouy–Chapman model (b), and C the Gouy–Chapman–Stern model. H is the
double layer distance described by the Helmholtz model. Ψs is the potential across the EDL.
Reproduced from48 with permission from the PCCP Owner Societies. Copyright 2014 Royal
Society of Chemistry.
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The relation between the counter ion concentration near the surface and the bulk
counter ion concentration is subject to Boltzmann distribution and is given by an equation:
C = C0e
−( −W
kBT
) (1.14)
where C is the counter ion concentration near the surface, C 0 is the bulk counter ion
concentration, W is work required to bring an ion closer to the surface from an infinitely
far distance, Ψ is the surface potential, kB - Boltzmann constant and T - temperature in
Kelvin.
The electric work to move an anion or a cation to the surface with potential Ψ is equal
to W − = −eΨ (for anion) and W + = eΨ (for cation),49 which transforms the Eq. 1.14
to:
C− = C0e
( Ψe
kBT
) (1.15)
C+ = C0e
−( Ψe
kBT
) (1.16)
where C− and C+ is the local anion and cation concentration near the surface respec-
tively, C 0 is the bulk ion concentration, Ψ is the surface potential, e - elemental charge
of electron (1.602×10−19 C), kB - Boltzmann constant and T - temperature in Kelvins.
Local volumetric electric charge density takes into account both anions and cation
local concentration and is given by:
ρe = e(C
+ − C−) (1.17)
where ρe is the local electric charge density in C/m3, C+ is the local anion and cation
concentration near the surface respectively, e - elementary charge of electron.
Furthermore, electrical potential and the local volumetric electric charge density are
bound together with Poisson’s equation:
∇2Ψ = ρe
εε0
(1.18)
where Ψ is the surface potential, ρe is the local electric charge density in C/m3, ε is
the dielectric constant (relative permittivity) of the solvent and ε0 is the permittivity of
vacuum.
Merging the Eq. 1.14 and 1.18, a Poisson-Boltzmann equation is derived
∇2Ψ = −C0e
εε0
(e
− Ψe
kBT − e ΨekBT ) (1.19)
where Ψ is the surface potential, C 0 is the bulk ion concentration, ε is the dielec-
tric constant (relative permittivity) of the solvent, ε0 is the permittivity of vacuum, e -
elemental charge of electron, kB - Boltzmann constant and T - temperature in Kelvins.
The Poisson-Boltzmann equation solution is the potential Ψ at a given distance, but
is rather difficult to solve. Several solutions were proposed, including the Debye-Hückel
theory, the main assumptions are: 1:1 salt solutions with cations of z valence and anions
of -z and the spherical symmetry. The Eq. 1.19 is transformed to:
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∇2Ψ = Ψ 2z
2eFC0
kBTεε0
(1.20)
κ2 =
2z2eFC0
kBTεε0
(1.21)
where Ψ is the surface potential, z - charge of the ion, C 0 - concentration of ions.
From the above, one can extract 1/κ, which is a very important parameter in FET
biosensing. It is called the Debye length (λD) and can be expressed also with the following
equation:50
λD =
√
ε0εrkBT
2NAq2I
(1.22)
where NA is the Avogadro number, q is the charge on an electron, and I is the ionic
strength of the solution.
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Debye screening Debye length can be thought as a measure of a charge carrier’s
net electrostatic effect in a solution and how far its electrostatic effect extends. The
potential distribution at a charged surface in contact with a liquid electrolyte predicts an
exponential decay of the surface potential with increasing distance from the electrode x
(see Fig. 1.12).
Figure 1.12 – A Potential distribution vs. distance from electrode surface (x = 0) with
the potential decaying by 1/e at the Debye length (1/κ). B A surface layer separates the
solid electrode surface from the liquid electrolyte. Ions are present within the surface layer
resulting in a almost stable Donnan potential, which drops sigmoidal close to the surface
layer/electrolyte interface. The decay is determined by the Debye length 1/κ but starts further
away from the sensor surface compared to A.
Debye screening has so far limited application of FET-based biosensors in real samples.
An increase in ion concentration reduces the Debye length due to charge screening by
counter-ions.51 Thus, the Debye screening length, which is a physical distance where the
charged analyte is electrically screened by the ions in the medium, strongly affects the
biosensor sensitivity in high ionic strength buffers.
The Debye length is inversely proportional to the square root of the ionic strength (see
Equation 1.22). For example, in 1 mM ionic strength aqueous solution, the Debye length
is approximately 10 nm, while in physiological solutions, where the ionic strength ∼150
mM, it is merely 0.3 nm.
To overcome the Debye screening, the following solutions have been proposed: i)
dilution of the fluid sample, ii) addition of a signal-enhancing label ("electronic ELISA"”),
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iii) the use of shorter receptors such as aptamers6,52,53 and antibody fragments,54 iv)
high-frequency measurements55 and, more recently, v) local desalting by a polyethylene
glycol layer (PEG).5,6 While highly effective in avoiding the Debye screening, the first two
approaches i) and ii) require pre-treatment of physiological samples, additional reagents,
washing buffers, and more complex liquid handling, which results in higher assay cost and
longer measurement times.
A solution to the Debye screening problem is proposed in the later chapters, where
semiconducting SWCNTs (Chapter 2) or graphene (Chapter 3) were used in as channels
in an electrolyte-gated field-effect transistor based immunosensors in physiological condi-
tions. Additional polymer (poly(ethylene glycol), PEG) layer was added, which can be
thought as the surface layer described in the Donnan model56 (see Fig. 1.12), where po-
tential at the solid surface (the Donnan potential ΨDon) remains almost constant within
the surface layer due to presence of ions in this layer. The Debye screening starts to play a
role further away from the electrode surface, namely close to the surface layer/electrolyte
interface. In this case, if an analyte binding event take place within the surface layer,
then a significant portion of its charge may be still detectable.
Figure 1.13 – An illustration of Debye screening limitation in FET-based (bio)sensors. In
low ionic strength solutions, it is possible to sense binding events far away from the surface
(antigen-antibody interactions), while in high ionic strength solutions, so far only small,
highly charged objects like ions or short DNA sequences were possible to detect.
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Electrolyte-gated field-effect transistor
Electrolyte-gated field-effect transistors differ significantly from classical ion-sensitive FETs.
As mentioned in the previous subsection, in the "classical" FET, the channel of the tran-
sistor is covered with dielectric on top of which a gate electrode can be placed (Fig. 1.14
A. In the EGFET configuration, the semiconducting channel is in direct contact with an
electrolyte instead of a conventional dielectric (Fig. 1.14 B).
The electrolyte covers the semiconductor surface and the mobile ions are even able to
penetrate into porous semiconductors. When a negative (positive) voltage is applied to
the gate electrode, the cations (anions) and anions (cations) move within the electric field
and accumulate at the gate and the semiconductor, respectively. An electric double-layer
(see Paragraph 1.2.2) at the electrolyte/semiconductor interface as well as the gate elec-
trode/electrolyte interface is formed. Additionally, compensating opposite charge carriers
are injected and accumulated within the semiconductor. Due to the nanometer thick-
ness of the electric double-layer, the effective capacitance of the liquid electrolyte as the
gate dielectric is in the range of 1-100 µF/cm2 and is about 1000 times higher than the
conventional silicon dioxide (SiO2) dielectric layer in a MOSFET.57
Also, voltages applied used for EGFETs are typically much smaller than those nec-
essary for "standard" FETs and must not exceed the water splitting voltages (<1.5 V,
vs. >10 V or even higher). Additionally, the adsorption of species on the surface of
liquid exposed channel can change the transitor’s characteristics in many ways:58 1) elec-
trostatic gating, 2) Schottky barrier effect, 3) capacitance change and 4) charge carriers
mobility change. These three characteristics (electrolyte compatibility, direct adsorption
of species on the surface and low gating potentials) make EGFETs ideal candidates for the
next generation of biosensors, particularly suitable for the detection and quantification
of biological molecules inside aqueous media. With the advances of nanotechnology, new
semiconducting materials were used as a channel in electrolyte-gated field-effect transis-
tors, e.g. graphene.59,60
Figure 1.14 – General scheme of an field-effect transistor (FET) (A) and an electrolyte-
gated field-effect transistor (EGFET) (B).
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Mechanisms of biosensing with carbon nanotube/graphene electrolyte gated
transistors Although electrolyte-gated CNT field-effect transistors have been first de-
scribed in 2002,61 until now, the physical mechanism that the (bio)sensing is based on,
is still debatable.62 Despite having significant differences, the mechanisms status expands
also to electrolyte-gated graphene FETs. Among candidates to the title of "biosensing
mechanism of CNT/graphene FET" are: 1) electrostatic gating effect,63–65 2) Schottky
barrier effects,66–68 3) changes in gate coupling,69 4) charge scattering across the nano-
material.70
Figure 1.15 A shows the first mentioned mechanism - electrostatic gating. The phe-
nomenon that occurs here is that the adsorbed charged species induce a screening charge
(doping) in the semiconducting carbon nanomaterial and thus shift the transfer curve (I SD
vs. V g). For example, positively charged molecules induce additional negative charge in
the nanomaterial causing n-doping and consequently shifting the transfer curve to more
negative gate voltages, and vice versa, negatively charged species cause p-doping and the
transfer curves to shift to more positive potentials.
The Schottky barrier effect (shown in Fig. 1.15 B) is based on adsorption of (bio)molecules
at the metal contacts that modulate the local work function and thus the band alignment.
The Schottky barrier (semiconductor/metal) changes in opposite directions for hole (p)
and electron (n) transport (Fig. 1.15 B, inset) resulting in characteristic asymmetric
conductance change for hole and electron branches of a transfer curve.
Low permittivity of adsorbed molecules (relative to the electrolyte) is the reason for
the reduction in gate capacitance (Fig. 1.15. For SWCNTs, the electrolyte interfacial ca-
pacitance is dominated by the quantum capacitance of SWCNTs.61 Thus the electrostatic
capacitance reduction due to biomolecule adsorption can only be the case for nearly full
surface coverage with said biomolecules. In that situation, permeation of ions through
the biomolecule layer can be hindered, but so far is a subject to dispute.71
The fourth proposed mechanism relies on the change in mobility of charge carriers
in the carbon nanomaterial (Fig. 1.15 D). This mobility is proportional to the effective
scattering time (time that the charge carrier travels through the atomic lattice before
it is scattered). There are two major sources of scattering of charge carriers in carbon
nanomaterials: intrinsic (specific to the nanomaterial itself) and extrinsic, which can
happen due to presence of neutral and charged impurities, defects etc. In principle, if an
adsorbed biomolecule is treated as an "impurity" at the surface of carbon nanomaterial,
it can change the charge carrier mobilities as shown in Fig. 1.15.
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Figure 1.15 – Calculated I-Vg-curves before (black) and after (red) protein adsorption for
four different sensing mechanisms. The bias voltage is 10 mV. A Electrostatic gating effect
corresponding to a 50 meV shift of the semiconducting bands downward. B Schottky barrier
effect that corresponds to a change of the difference between metal and SWNT work functions
of 30 meV. In panels a and b, left and right insets illustrate the corresponding changes
in the band diagrams for hole and electron doping respectively. C Capacitance mechanism
for a 90% coverage of SWCNT with protein. In panels c and d, the insets illustrate the
corresponding changes in the band diagrams. D Mobility mechanism that corresponds to
a mobility reduction to a mere 2% of the initial value. Reprinted with permission from.58
Copyright 2008 American Chemical Society."
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1.2.3 Surface characterization methods
Raman spectroscopy
Raman spectroscopy is a powerful spectroscopic technique based on inelastic scattering of
monochromatic light (mostly laser). The frequency of photons emitted by a laser changes
upon interaction with a sample: photons are scattered by the surface, which changes their
frequency (shift up or down called Raman effect). Those shifts provide information about
vibrational, rotational and other low frequency transitions in molecules. Study of solid,
liquid and gaseous samples is possible with Raman spectroscopy.
Raman spectroscopy can be used for characterization of various carbon based (nano)
materials disordered and amorphous carbons, fullerenes, diamonds, carbon chains and
polyconjugated molecules and most importantly for this work - for carbon nanotubes72
or graphene.73
Raman techniques are particularly useful for graphene because the absence of a band-
gap makes all wavelengths of incident radiation resonant, thus the Raman spectrum con-
tains information about both atomic structure and electronic properties.74 It can provide
information about the layer structure (number) of graphene and the density of defects.
For example, perfect single-sheet graphene the intensity ratio of 2D to G should follow
the rule I2D
IG
 1.
Typical graphene Raman spectra are shown in the Fig. 1.16a.The G band (1580 cm−1)
is an in-plane sp2 C-C stretching mode, the 2D band (2675 cm−1) originates from an in-
plane breathing-like mode of the carbon rings. The D-band resonance (1350 cm−1) is a
disorder-induced scattering process and is observed when there is symmetry breaking on
the hexagonal sp2-bonding lattices. The observation of a D band in the Raman spectra
is, therefore, related to either the presence of defects (e.g., vacancies, dopants) or to the
presence of amorphous-carbon material in the sample.
Typical carbon nanotube Raman spectra are shown in the Fig. 1.16b. Raman spec-
troscopy allows to distinguish the diameter of the carbon nanotubes. The spectra show
characteristic for CNTs: the radial breathing modes (RBM), D-band, G-band and G’
band features, in addition to weak double-resonance features associated with the M-band
and the iTOLA second-order modes. The RBM is unique to carbon nanotubes and is not
observed in other carbon materials. It has the very important property that is the RBM
mode frequency is proportional to the inverse tube diameter. The G band in SWNTs
is composed of two stronger peaks (G+ and G–) related to the circumferential (TO) and
axial (LO) atomic vibrations.75
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(a) (b)
Figure 1.16 – A Raman spectra of pristine (top) and defected (bottom) graphene. The
main peaks are labelled. Reprinted with permission from.74 Copyright 2013 Nature Publishing
Group. B Raman spectra from a metallic (top) and a semiconducting (bottom) SWNT at
the single-nanotube level. Reprinted from75 with permission. Copyright 2005 Elsevier.
Quartz crystal microbalance
An analytical technique allowing us to directly measure mass changes on the surface upon
binding (surface modification, biosensing) is quartz crystal microbalance. This technique,
established in 196476 is based on a piezoelectric property of quartz - upon applied voltage,
the quartz crystal oscillates. When molecules interact with the surface of the crystal, the
frequency of oscillations changes (binding - decreases, unbinding - increases). A QCM
chip consists of a thin disk of single crystal quartz, with metal electrodes deposited on
each side of the disk and the AC voltage is applied across the crystal, causing vibrational
motion of the crystal at its resonant frequency.
Sauerbrey77 first showed that in vacuum the amount of added mass to the electrodes
is linearly related to the resulting shift in resonant frequency of the oscillator:
∆m = −C∆f (1.23)
where ∆m is the mass change, C is a constant that depends only on the thickness of
the quartz slab and on the intrinsic properties of the quartz (for commonly used 5 MHz
fundamental frequency crystals C = 17.7 ng/Hz78) and ∆f is the frequency change.
The Sauerbrey equations rely on the following assumptions: 1) the added mass is evenly
distributed over the electrode(s) and is much smaller than the weight of the quartz disk,
i.e., ∆f  f, 2) the mass is rigidly attached to the electrodes, with no slip or deformation
due to the oscillatory motion. Those assumptions limit the use of Sauerbrey equation
when working with liquids and biological samples due to viscoelastic properties and uneven
distribution of adsorbed species on the surface under study.79
Another important feature of QCM is the ability (in some configurations) to measure
the dissipation (the loss of energy per oscillation period divided by the total energy stored
in the system). Basically, when the AC voltage is turned off, the oscillation decays
exponentially ("rings down") and is recorded to extract the resonance frequency and the
dissipation factor (D). Dissipation can also be expressed as the resonance bandwidth
divided by the resonance frequency. The dissipation gives additional information about
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the rigidity of the layers adsorbed on the surface of the crystal - when soft layers (e.g.
PEG) are adsorbed, the dissipation increases, whereas when rigid layers are formed -
decreases. QCM has also been used in liquids80 and coupled with electrochemistry81
became a powerful method for biosensing.
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1.3 Carbon based nanomaterials
Carbon is one of the most widespread elements in the universe and the one that life
as we know it, is based on. Due to its electron configuration (1s)2(2s)2(2p)2, it is able
to form different kinds of covalent bonds, including catenation - the property to form
long chains of its own atoms. Elemental carbon may occur in different allotropes having
the same hybridization, for example sp2 - fullerene (0 dimensional), carbon nanotubes
(1 dimensional), graphene (2 dimensional), graphite (3 dimensional).82 The article that
started the carbon nanotube trend was published in 19913 and from then, the interest
in CNTs only rose 1.17. The experimental proof for graphene was published in 20044
and it attracted thousands of researchers (Fig. 1.17). In 2018, the number of records
in Scopus database for "graphene" exceeded 100.000 and in 2016 the number of records
for "graphene" was for the first time in history higher than the number of records for
"carbon" AND "nanotubes" query. Since carbon nanotubes can be treated as rolled-
up graphene, graphene basic properties need to be addressed before introducing carbon
nanotubes. Both carbon nanotubes and graphene are proven to be applicable in the Point-
of-Care diagnostic devices and due to their unique properties, they make the devices highly
sensitive, specific, rapid in analysis, low cost, and easy to use. Biosensors based on CNTs
and graphene are improved in terms of portability, functionality, reliability, and real-time
diagnosis for Point-of-Care analysis.83 The basic properties of both carbon nanotubes and
graphene will be discussed in this section.
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Figure 1.17 – Number of records in Scopus database every year from 1985 to 2018 for the
queries: "fullerenes", "carbon" AND "nanotubes", and "graphenes", respectively. Note the
increase in records after two milestones: official carbon nanotubes "discovery" by Iijima et
al. (1991)3 and official graphene "discovery" by Geim and Novoselov et al. (2004).4 Data
retrieved and analysis done on 24.04.2019 from www.scopus.com online scientific publication
database.
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1.3.1 Graphene
Graphene is a flat monolayer of carbon atoms in a honeycomb lattice.84 As mentioned
before, sp2 hybridized carbon atoms in graphene are bonded via σ bonds. Due to its
hybridization, each carbon atom has an unpaired electron (pi electron), which due to
the structural symmetry is delocalized. Because of this delocalized electrons, graphene
possesses high electrical conductivity and the extremely high mechanical resistance of
graphene comes from very short C-C bonds - 0.142 Å compared to 0.154 Å in diamond
(sp3 hybridized carbon atom crystal).85
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Figure 1.18 – Bravais lattice of graphene. a1 and a2 are the basis vectors of same length
(|a1| = |a2| = a0 =
√
3b), which form a pi/3 (60 °) angle, b ≈ 1.42 Å - carbon-carbon bond
length.
The unit cell is spanned by the two vectors, a1 and a2 and contains two carbon atoms.
The basis vectors (a1, a2) are of the same length, |a1|=|a2|=a0=
√
3b and form an angle
pi/3 (60°), where a0 is the lattice constant and b ≈ 1.42 Å is the carbon-carbon bond
length. The components of those vectors are, respectively: a1 = (
√
3/a0, a0/2), a2 =
(
√
3/a0,−a0/2). Additionally, the surface area of the cell can be calculated - Ag =√
3a02/2.
Due to hexagonal honeycomb lattice of graphene, with two carbon atoms per unit cell
(Fig. 1.19 A), graphene exhibits unique electronic properties86(Fig. 1.19 B). The valence
band is formed by the pi-states and the conduction band by the pi*. The two bands touch
at six points, the so-called Dirac or neutrality points. Due to the high symmetry, they
can be reduced to a pair, K and K’, which are independent of one another. In the low
energies regime (relevant for electron transport), the bands exhibit a linear dispersion
and the band stucture can be displayed as two cones touching at EDirac (Fig. 1.19 C, D).
The two bands touching at EDirac indicates that graphene is a zero-band semiconductor
(sometimes referred to zero-overlap semimetal) and because of the symmetric band struc-
ture, graphene exhibits ambipolar behaviour: both electrons and holes being the charge
carriers82 with Fermi velocities of νF ≈ 106 m/s.87
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Figure 1.19 – A Hexagonal honenycomb lattice of graphene with two atoms (A and B) per
unit cell. B The 3D bandstructure of graphene. C Band structure of graphene plotted along
the symmetry points. D Approximation of the low energy bandstructure as two cones touching
at the Dirac point. The position of the Fermi level determines the nature of the doping and
the transport carrier. Reprinted with permission from.86 Copyright 2010 American Chemical
Society.
Graphene synthesis
Graphene synthesis can be divided into two subgroups taking into account the strategy:
top-down (e.g. mechanical exfoliation) and bottom-up (e.g. chemical vapour deposition
- CVD).88 Briefly, top-down (TD) fabrication strategy implies that there is a bulk (big-
ger) starting material (graphite) which can be turned into the desired (smaller) material
(graphene) by means of machining like e.g. cutting, exfoliation or ablation. The bottom-
up (BU) on the other hand is based on fabrication of the material (graphene) from its
elementary parts (carbon containing gases). Historically, TD has been applied first in e.g.
silicon industry.89
Graphene was first mechanically exfoliated on purpose in 20044 using the scotch tape
method: the graphite flakes were spread on a substrate, a piece of scotch tape was glued
attached and then peeled-off to separate the layers of graphite. After several iterations of
this low-budget process, graphene flakes could be obtained. This work initiated a graphene
revolution or "graphene rush". Other top-down methods include liquid exfoliation starting
from graphite using modified Hummer’s method to obtain graphene oxide (GO)90 and
then reducing the graphene oxide to obtain reduced graphene oxide (rGO). The biggest
problem of TD methods is that it is not possible to obtain large scale high quality uniform
graphene layers.
Epitaxial growth on silicon carbide (SiC) is an interesting alternative for acquiring
high-quality few-layer and large scale graphene sheets. Briefly, due to difference in va-
por pressures between carbon and silicon, the Si atoms from an annealed SiC surface
(>1000 ° C) desorb leaving the C atoms, which form graphitic layers. The process is
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normally performed in (ultra-)high vacuum giving a few-layer graphene. Interestingly,
using argon environment instead and temperatures above 1650 °C, it is possible to obtain
single-layer graphene.91
More recently, chemical vapor deposition (CVD) from carbon containing gases on
catalytic metal surfaces became a wide-spread graphene growth technique. Starting from
nickel as the growth substrate and achieving from 1-12 graphene layers,92 to copper to
achieve a purely surface mediated, self limiting process that stops after a monolayer is
formed.93 Various other graphene-CVD processes were developed and optimized over the
last ten years.94
Although the mechanical exfoliation of graphene provides very high quality and purity,
the size of obtained flakes is very small and not suitable for industrial applications. On
the other hand, graphene growth on surfaces via e.g. CVD or epitaxial methods, allows a
much larger size of the graphene layers and a high controllability, which is the pre-requisite
for industrial production.
To use a CVD grown graphene in e.g. constructing a field-effect transistor, a transfer
process needs to be performed. One of the most widespread methods is to coat the as-
grown graphene on copper foil with poly(methyl methacrylate) (PMMA)95 as a protection
layer. The next step is to wet etch the copper (e.g. with (NH4)2S2O8) resulting in graphene
covered with PMMA floating on the surface of the aqueous solution of the etchant. After
transfering into clean solvent (H2O), graphene/PMMA can be collected with an arbitrary
substrate (SiO2, glass, PET etc.) and further processed (e.g. patterning, removing PMMA
with acetone).
The growth of graphene and transfer process into the final substrate have a huge
influence on the performance of the manufactured device. Continuous CVD graphene
films are usually polycrystalline and with small grain size (several micrometers). The
grain boundaries between each grain of graphene were found to negatively impact both
charge carrier transport and mechanical properties.94 During the transfer process, since
the less-than-nanometer thick and micro- to milimiter sized graphene is handled with
macroscale methods and techniques (e.g. wet etching, PMMA removal, baking etc.),
holes and ripples can occur which naturally would again affect the properties of the final
graphene device.
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1.3.2 Carbon nanotubes
Carbon nanotubes can be imagined as rolled-up graphene sheets with up to 3 nm in
diameter - single-walled NTs, and up to 100 nm in diameter - multi-walled NTs, and
typically up to µm length. Since there are many ways of selecting a stripe to roll up, there
are correspondingly many different nanotube structures. The nanotube nomenclature is
based on a graphene sheet chirality vector (Fig. 1.20 A). T is the nanotube axis, and C
is the "roll up" vector. a1 and a2 are the unit vectors of graphene and n and m are the
indeces. There are basically 3 different types of single-walled nanotubes, based on the
(n,m) nomenclature (Fig. 1.20 B):
• (n,0) - when m = 0, the nanotube is a zigzag type (achiral)
• (n,n) - when n = m, the nanotube is an armchair type (achiral)
• (n,m) - all the other n and m combinations
Figure 1.20 – Atomic structure of carbon nanotubes. A Derivation of nanotube structure
from graphene. A single-walled nanotube is equivalent to a rolled-up graphene stripe (shaded,
with the direction of rolling chosen so that the printed pattern faces outward). The chiral
vector C spans the nanotube circumference (inset) and connects lattice sites that are brought
together by rolling up. The unit cell of the nanotube (much larger than the unit cell of
graphene) is outlined by dashed lines, and the unit vector T is indicated. Graphene coordi-
nates (x, y, z), nanotube coordinates (t, c, r), and the chiral angle Θ are also marked. B
Nanotubes are divided into three classes according to their chiral indices: zigzag, armchair,
or chiral. C Carbon nanotube imaged by transmission electron microscopy (TEM). D Car-
bon nanotube imaged by scanning tunelling microscopy (STM). Reprinted with permission
from96 Copyright 2015 by the American Physical Society.
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Zigzag and armchair nanotubes are so called because of the shape of the edge formed by
a cut perpendicular to the nanotube axis. Electronic band structure calculations predict
that the (n,m) indices determine whether a SCWNT is a metal or a semiconductor.97 For
a given (n,m) nanotube, if n = m, the nanotube is metallic; if n - m is a multiple of 3
and n 6= m and n×m 6= 0, then the nanotube is quasi-metallic with a very small band
gap, otherwise the nanotube is a semiconductor.96
The diameter of the nanotube can be calculated using the following equation:85
d =
a
pi
√
(n2 + nm+m2) (1.24)
where d is the diameter, a = 0.246 nm and n and m are the parameters from the
rolling vector.
In a tight-binding model, the diameter of SWCNTs can be used to approximate the
band gap using the equation:98
Eg = γ(
2b
dCNT
) (1.25)
where γ is the hopping matrix element (∼3 eV), b is the C-C bond length and dCNT
is the carbon nanotube diameter.
Carbon nanotube synthesis
Almost all carbon nanotube synthesis methods require a solid substrate and a gaseous
precursor. The three main techniques are: 1) carbon arc discharge, 2) laser ablation and,
a family of techniques mostly explored 3) chemical vapor deposition (CVD). Arc discharge
nanotube synthesis is based on flowing a high current between two graphite electrodes
(often catalyst - Co, Ni, Fe covered) in gas (helium mostly, methane or hydrogen is
also used) atmosphere thus creating an electrical arc between them (which can heat the
system up to 1700 °C).99 The carbon atoms evaporate from the anode and deposit on the
cathode in a form of carbon nanotubes. By using of high-power laser vaporization (yttrium
aluminum garnet (YAG) type), a quartz tube containing a block of pure graphite is heated
inside a furnace at 1200 °C, in an Ar atmosphere.100 The aim of using laser is vaporizing
the graphite within the quartz. Finally, the chemical vapor deposition technique, like
with graphene, enables fine tuning of the quality and type of carbon nanotubes. For
CNT synthesis, the most used CVD type is catalytic CVD including thermal and plasma
assisted processes. Briefly, a heated reactor to ∼ 700 °C is fueled with carbon containing
gases, which break down on catalyst (metal nanoparticle - Ni, Co, Fe) covered substrate
(Si) with holes, serving as a nanotube growth template.101
A special type of CVD worth mentioning is high-pressure carbon monoxide dispropor-
tionation (HiPCO), which results in high purity (99%) single-walled carbon nanotubes
with small diameters (0.8 - 1.2 nm).102 Another example of "special" CVD is CoMoCat
- perhaps the most scalable process which uses a fluidized bed reactor similar to those
used in petroleum refining, albeit, currently on a much smaller scale.103 The supported
catalyst approach provides a substantial degree of chirality control during synthesis. Both
of the methods are commercialized.
Synthesizing high purity carbon nanotubes pose no problem nowadays. The challeng-
ing part for the application of SWCNTs in devices like transistors or logic gates is their
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polydispersity and thus mix of metallic and semiconducting nanotubes. A number of
methods to select only the SWCNTs of desired qualities were developed including DNA
wrapping, density gradient ultracentrifugation, gel chromatography, and conjugated poly-
mer wrapping.104 Selective dispersion by wrapping with conjugated polymers has become
one of the most effective and popular methods to produce semiconducting nanotube dis-
persions with high selectivity (>99.8 % s-SWCNTs) and high yield.105 Depending on the
chosen nanotube raw material and wrapping polymer the obtained dispersions contain
mixtures of certain semiconducting SWCNT species with different diameters and thus
different bandgaps.
While being extremely promising due to their high sensitivity, single walled carbon
nanotube field-effect transistors have faced significant fabrication challenges, in part be-
cause the selective production of semiconducting CNTs is very difficult and the presence
of metallic CNTs can compromise the transistor performance and device reproducibil-
ity. Recently, tremendous progress has been made in CNT separation, and high per-
formance transistors based on CNTs networks have been demonstrated.106,107 Although
there has been several notable articles about biosensors made from semiconducting CNT
networks,108,109 the field seems to be underexplored.
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1.3.3 Graphene and CNT comparison
Since both the nanomaterials were used in this work, it is worthwhile to compare the two.
When it comes to the charge transport properties of graphene and carbon nanotubes, it
seems that they are highly similar. Both the nanomaterials exhibit ambipolar (both hole
and electron) transport86 and the electric capacity for both was reported to be above
109 A cm−2.110,111 The carrier mobility in semiconducting single-walled carbon nanotubes
was measured to be 80,000 cm2V−1s−1,112 while the mobility of exfoliated graphene
ranges from 100,000 2V−1s−1 113 on insulating substrates to 230,000 2V−1s−1 for suspended
graphene.87 However, there are also other, more basic differences i.e. dimensionality (1D
vs. 2D) and the presence of a band gap in semiconducting nanotubes. From the practical
point of view, nanotubes, being heterogeneous in diameter and type, make producing a
well-defined starting material for technology, a problem. Also, CNT network FET require
the positioning of the CNTs in a specific direction, with desired density. Graphene,
on the other hand, is well-defined and its planar geometry allows the use of the highly
advanced semiconductor industry techniques. The highest achieved so far ON/OFF ratios
for graphene transistors are ∼10,114 while the SWCNT network transistors105,115,116 easily
exceed 106. A good overview of electrolyte-gated SWCNT network FET vs. graphene
FET transfer curves is shown in the Fig. 1.21. In this particular case, Trivial Transfer
Graphene (commercially available single-sheet CVD grown graphene transferred into a
hydrogel making the transfer process trivial) used as a FET transducer in Chapter 3 and
polymer sorted semiconducting SWCNT network FET used in Chapter 2 are presented.
Figure 1.21 – Comparison between transfer curves of FET devices based on two different
carbon nanomaterials: graphene and semiconducting single-walled carbon nanotubes. In both
cases, the source-drain voltage VSD = 100 mV. A Transfer curves presented with current in
linear scale. B Transfer curves presented with current in logarithmic scale.
2 | Carbon nanotube field-effect
transistors with nanobody receptors
for immunodetection
in physiological solutions
The study described in this chapter was previously published as "Highly sensitive, selective
and label-free protein detection in physiological solutions using carbon nanotube transistors
with nanobody receptors" in Sensors and Actuators B: Chemical117 with Marcin S. Filipiak
as first author.
2.1 Introduction
Field-effect transistor (FET) based transducers were proven to be highly sensitive and
found applications in environmental monitoring, screening or even diagnostics. As for the
choice for FET channels, a wide variety of nanomaterials were explored including semi-
conducting nanowires,118–120 carbon nanotubes,121–124 graphene,6,125–127 organic semicon-
ductors128,129 and other layered two-dimensional materials.130,131 Carbon nanotubes seem
to be particularly interesting due to excellent electronic and mechanical properties as well
as the option of solution-based processing, which can be implemented in low-cost printed
electronics132 and sensors.
While being extremely promising due to their high sensitivity, single walled carbon
nanotube FETs have faced significant fabrication challenges, in part because the selective
production of semiconducting CNTs is very difficult and the presence of metallic CNTs
can compromise the transistor performance and device reproducibility. Furtunately, the
progress in sorting the CNTs has overcome this challenge resulting in high purity semicon-
ducting nanotubes with remarkable current on/off ratios and reproducible device charac-
teristics.116,122,124,133–137 Although there has been examples of carbon nanotube field-effect
transistor based biosensor made from single carbon nanotubes,58,123,138,139 to date, sur-
prisingly biosensors made from semiconducting CNT networks is a rather underexplored
field given the potential.108
FET-based (bio)sensors working principle is based on adsorption of charged species
on the sensors surface, in case of electrolyte-gated FETs - the semiconducting channel
surface. The charges added through this binding event cause a surface potential change
and thus a current change in the transistor channel via the field effect. However, two
main issues have so far limited their use beyond proof-of-principle studies: 1) Debye
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screening, in which the analyte charge is screened by electrolyte ions and 2) significant
non-specific adsorption of other species present in complex matrices (e.g. serum, blood).
In physiological conditions, where the ionic strength oscillates between 100 and 200 mM,
the effective distance for charge detection is <1 nm.
Several solutions have been proposed in order to sense beyond the Debye screening
length: 1) dilution of the fluid sample,140 2) enrichment followed by elution into low
ionic strength buffer,141 3) addition of a signal-enhancing label ("electronic ELISA"),142
4) use of polyelectrolyte multilayer films,143 5) high frequency AC measurements,55 6)
the use of shorter receptors6,7,14,15,52–54,59,144,145 and finally 7) co-immobilization of recep-
tor within a polyethylene glycol layer (PEG).6,7,59 While highly effective in avoiding the
Debye screening, the mentioned approaches require pre-treatment of physiological sam-
ples (1), additional reagents (3), washing buffers (2), elaborate labelling (3) and more
complex liquid handling (1, 2 and 3), which results in higher assay cost and longer mea-
surement times. Polyelectrolyte multilayer films (4) seem like an interesting solution, but
the preparation times of such films are very long and cumbersome. The high frequency AC
measurements (5) require special instrumentation, which limits the use in Point-of-Care
environment.
The approach of using smaller receptors (6) seem to be the prevailing trend. The
typical antibody receptor size is on the order of 10-15 nm (M w ∼ 140 kDa), which makes
the direct detection of antigens (e.g. proteins) very difficult. The receptor size is crucial
for the FET-based biosensors in two ways: a) smaller receptors bring the antigen-receptor
interaction closer to the surface and b) the density of the smaller receptors on the surface
can be higher, increasing the amount of binding events in the first place. To overcome the
Debye screening, smaller alternative receptors were proposed including aptamers6,52,144
(∼5-15 kDa,∼2-3 nm), F(ab’)2 fragments7,59 (∼110 kDa, ∼7-8 nm), single Fab fragments
(∼50 kDa, ∼7-8 nm)14,15 or single-chain variable fragments (scFv, ∼27 kDa).145 Camelid
heavy-chain VHH antibody fragments (also called "nanobodies") are one of the shortest
available biological receptors (∼13 kDa, <3 nm) and the easy production and stability in
a range of different conditions,16 make them even more suitable receptor for FET-based
biosensors. Yet, their usefulness as recognition elements of a biosensor was proven only
in photoelectrochemical17,18 and electrochemical19,20 formats, not in combination with
transistor-based sensors.
On the other hand, using short receptors alone may not be sufficient to achieve suffi-
cient signals, as a large part of the analyte may be still screened by the electrolyte ions due
to very short Debye length in high ionic strength solutions (<1 nm). Therefore, the use
of poly(ethylene glycol) (PEG) layer co-immobilized with the receptors (7) is a promising
strategy for overcoming the Debye screening limitation and was proven to work even in
undiluted serum.7,59
In this work, the combination of using green fluorescent protein (GFP - model anti-
gen) specific nanobody receptors (6) along with poly(ethylene glycol) (7) were used to
overcome the Debye length problem. First, a systematic study of the "PEG effect" is
carried out by comparing two different nanobody-coated surfaces, with and without the
addition of PEG. The surface modification is carried out directly on the semiconducting
SWCNT network FET channels. Strikingly, even without PEG, significant signals are
measured which is attributed to the small size and random orientation of nanobodies on
the surface. Additionally, the signal is strongly enhanced in the presence of PEG even in
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high ionic strength buffer. With the PEGylated devices, highly sensitive, selective and
label-free immunosensing with a low detection limit (<1 pM)is demonstrated. Finally,
the sensor stability is assessed, where signal vs. time is measured and compared with
other biosensing platforms, showing extraordinary stability of semiconducting CNTs vs.
conventional semiconductors.
2.2 Results
2.2.1 Characterization of the electrolyte-gated CNT FET
The single-wall carbon nanotube network FETs were operated in an electrolyte-gated con-
figuration (see Subsection 1.2.2), as shown in Fig. 2.1 A. The semiconducting SWCNTs
were enriched using conjugated polymer sorting method and aligned in an AC electric
field following a previously published protocol.115,146 More details are given in Section
6.1. Electrical characterization i.e. transfer curves are presented in Figure 2.1 B. All mea-
sured transistors (n = 15) showed ambipolar behavior (both hole and electron transport)
with small hysteresis, current on-off ratios exceeding 103 at low gate voltages, and steep
subthreshold swings >110 mV/dec which can be explained by highly efficient electrolyte
gating through the double-layer capacitance. An atomic force micrograph of a typical
SWCNT network is shown in Figure 2.1 C. The two horizontal stripes at the top and
the bottom of the image are the edges of the gold electrodes with a dual function: firstly
used to align the carbon nanotubes in an electric field applied between the electrodes,
and next, used as the source and drain electrodes of the FET. Between the electrodes,
carbon nanotube network is seen orientated perpendicular to the gold electrodes. The
geometric channel dimensions are defined by the interdigitated gold contacts, with the
nominal channel length Lgeom = 20 µm and the channel width W geom = 2 mm. Single
nanotubes do not bridge the whole channel, since their length varies between 0.3 – 4 µm,
but the network allows charge percolation pathways between source and drain.147 The av-
erage CNT density over the width of the channel is estimated to be around 5-6 µm−1 and
taking into account the diameter of a single nanotube (0.9-1.9 nm), the effective channel
width is in the range of W eff 10 - 20 µm, which is only ∼ 0.5-1% of the geometric channel
width (W geom = 2000 µm).
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Figure 2.1 – A Schematic illustration of the measurement setup. The semiconducting
SWCNT network is aligned between interdigitated Au electrodes. Additionally, the contacts
are passivated with SU-8 photoresist to avoid leakage current. To provide different liquids to
the sensing surface, a microfluidic PDMS chamber with PTFE tubing is used. The Ag/AgCl
reference electrode is placed in the middle of the microfluidic channel. B Typical transfer
curves in both voltage sweep directions. The hysteresis is very small. C AFM image of
the electric field aligned SWCNT network. Horizontal stripes at the top and bottom are the
edges of the gold electrodes used to align SWCNTs. The same electrodes were later used as
source and drain contacts for electrical measurements. The network shows a preferred overall
orientation perpendicular to the contact lines. The estimated SWCNT density is 5-6 µm−1.
From this density, the effective channel width can be estimated to be 10-20 µm. The channel
length is 20 µm. Reprinted from.117 Copyrights 2017 Elsevier.
2.2.2 Surface functionalization of CNT FET
To construct a biosensor, CNT FET were functionalized using non-covalent pyrene chem-
istry (based on pi-pi stacking, see Paragraph 1.1.3) to preserve the devices’ remarkable
electronic properties. 1-pyrenebutyric acid (PBA) (for chemical structure see Fig. 1.5 B)
was used as a bifunctional linker molecule between the CNTs (binding via pyrene moiety)
and nanobodies (binding via -COOH functional group, used to aminocouple NH2 from
nanobody surface lysines via EDC/NHS chemistry, see Paragraph 1.1.3). To enhance
the biosensor signal in high-ionic strength, PEGylated pyrene derivative (mPEG pyrene,
10 kDa) was co-immobilized. A simple scheme of surface modification with the linker
molecule PBA and the mPEG-pyrene can be seen in Fig. 2.2 A.
2.2. RESULTS 41
Figure 2.2 – Measurements of bare (i.e. after THF cleaning) and coated SWCNTs in
different ionic strength solutions, prior to receptor immobilization. A The surface func-
tionalization was based on non-covalent pi-pi stacking of 2 pyrene derivatives on SWCNTs:
pyrenebutyric acid (PBA) as a linker for the receptor molecules, and mPEG-pyrene (10 kDa)
for signal enhancement.5 Transfer curves of bare (B) and coated SWCNTs (C) in 3 differ-
ent Tris buffer concentrations (CTris). The curves of bare SWCNTs shift to more negative
potentials with increasing CTris, whereas nearly no shift is visible for the modified SWCNTs.
The voltage VAg/AgCl at 1 µA is shown (D) for bare and coated SWCNTs from B and C.
Reprinted from.117 Copyrights 2017 Elsevier.
Before attaching the receptor molecules, the bare and PBA+PEG modified SWCNTs
were characterized in different ionic strength solutions (Fig. 2.2 B-C). As shown in Fig.
2.2 B, the transfer curves of bare SWCNTs shifted to more negative values when exposed
to increasing ionic strength. The voltage at I SD = 1 µA shifts by approximately -35
mV/dec (Fig. 2.2 D), which can be attributed to the non-specific interaction of alkali
ions with conjugated pi systems and defect sites.148 In the case of PBA coated CNT FET,
similar ion dependence was observed (32 mV/dec, not shown), whereas the whole transfer
curves were shifted by ∼ 20 mV towards more negative values, ionic strength independent.
This can be explained by charge transfer doping of SWCNTs by the COOH groups.149
The ionic strength dependence is strongly suppressed, when a PBA+mPEG-pyrenes are
attached to the surface of carbon nanotubes (Fig. 2.2 D), (the shift is <-5 mV/dec). This
observation suggests that co-immobilized poly(ethylene glycol) layer effectively reduces
ion adsorption on SWCNT surface.
2.2.3 Electrical characterization of VHH immobilization on CNT
FET
After the surface functionalization, GFP-specific VHH was attached to the PBA (or
PBA+PEG) modified carbon nanotubes via the EDC/NHS aminocoupling (Fig. 2.3).
The VHH immobilization resulted in a significant voltage shift to more negative poten-
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tials of the transfer curve for both PBA only (Fig. 2.3 A) and PBA+PEG (Fig. 2.3 C)
coated SWCNTs, which is expected due to the positive charge of VHH at pH 7 (theo-
retical isoelectric point = 7.18). A larger shift was obtained for the PBA+PEG surface
(∼50 mV, Fig. 2.3 D) rather than for PBA only (∼25 mV, Fig. 2.3 B), which may be
due to lowered dielectric constant of the surface in the presence of PEG.5 The complete
immobilization protocol is further described Section 6.1.
Figure 2.3 – Immobilization of VHH on PBA only (A, B) and PBA+PEG (C, D) coated
SWCNTs. Typical transfer curves in 100 mM Tris buffer for the surfaces prior to VHH
immobilization (black lines) and after VHH immobilization (red lines) shown for PBA func-
tionalized (B) and PBA+PEG functionalized (D) surfaces. Due to binding of VHH, the
transfer curves shift to more negative potentials because VHH is positively charged at pH 7.4.
The shifts are larger for PBA+PEG (∼50 mV) than for PBA only (∼25 mV). Reprinted
from.117 Copyrights 2017 Elsevier.
2.2. RESULTS 43
2.2.4 QCM reference measurements: GFP specific
VHH immobilization and GFP binding
The immobilization of VHH as well as binding of GFP was also confirmed by indepen-
dent quartz crystal microbalance (QCM, see Section 1.2.3) measurements (Fig. 2.4).
Gold QCM chips were functionalized first with 6-mercaptohexanoic acid to assemble a
monolayer with functional -COOH groups. After that, VHH was aminocoupled to the
functionalized QCM chips via EDC/NHS chemistry. The surface modification steps de-
tails are provided in Chapter 6.
Figure 2.4 – A Quartz crystal microbalance (QCM) results showing oscillation frequency
changes ∆f as a function of time ∆t for 2 different sensor chips. The arrows indicate the
exchange of different solutions as described in the text. The frequency decreases upon addition
of VHH and GFP, indicating successful binding that cannot be easily removed by washing in
buffer. B The frequency change was converted to the areal mass change ∆mA using the
Sauerbrey equation (Equation S1). C, D The binding curves for 100 nM TSH obtained with
sensor chip 1 (C) and sensor chip 2 (D) were fitted using Equation S2 (association; red
lines) and Equation S3 (dissociation; green lines). The dissociation constants Kd estimated
for both chips agree well with each other and were used for comparison (Tab. 2.2). Reprinted
from.117 Copyrights 2017 Elsevier. These measurements were performed by Arne Knudsen.
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The areal mass change ∆mA can be estimated from measured frequency changes ∆f
using the Sauerbrey equation77 (Equation 1.23; Fig. 2.4 B). To estimate the dissociation
constant KD=k off/k on, where k off is the dissociation rate and k on is the association rate,
the GFP binding data were fitted using the following equations:127
∆mA = ∆mA,eq × (1− e(−(konC+koff )t)) (2.1)
∆mA = ∆mA,eq × (e−koff t) (2.2)
where ∆mA is the sensor response vs. time t, ∆mA,eq is the equilibrium response, C
is the GFP concentration (100 nM). The fits for 2 different chips are shown in Fig. 2.4
C, D and yield similar KD values. The resulting values agree well with previous reports
and with the results of FET study (Tab. 2.2).
2.2.5 Effect of PEGylation on GFP binding
to the VHH modified CNT FET surface
To investigate the effect of PEG on the GFP specific binding signal, VHH was again
immobilized on both the PBA+PEG modified surface (Fig. 2.5 A) and on the control
SWCNT samples modified with PBA only (Fig. 2.5 D). Both biosensor surfaces were then
introduced to different GFP concentrations in 1 mM and 100 mM Tris buffer. The transfer
curves are shown in Fig. 2.5 B for PEGylated surface and F for the non-PEGylated case.
The readouts of transfer curves 2.5 B and E at currents indicated by a dashed line are
shown in Fig. 2.5 C and F, respectively. In both cases, the transfer curves shift to
more positive values with increasing GFP concentrations, wherein the PEGylated surface
exhibits higher shifts. Importantly, the signal of the PEGylated sensor exhibits a 3-fold
enhancement in 100 mM buffer compared to the non-PEGylated surface (25 mV vs. 8
mV for 100 nM GFP) as predicted by Haustein et al. analytical model of the PEG
effect.150 Signal (voltage shift) enhancement in low ionic strength (1 mM) is lesser and
amounts to an approximately 2-fold increase (47 mV vs. 25 mV for 100 nM GFP). Strong
positive impact on the maximum achievable sensor response by using PEGylated surface
is indicated, which is in agreement with previous reports.5–7
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Figure 2.5 – Comparison of GFP detection with PEGylated (A-C) and non-PEGylated
SWCNT FETs (D-F). The surface of the SWCNTs was modified either with a mixture
of pyrene butyric acid (PBA) with methyl PEGylated pyrene (A) or with PBA only (D).
Camelid nanobodies (VHH), specific to green fluorescent protein (GFP), were then immo-
bilized on both surfaces and exposed to GFP solutions to assess the VHH-GFP binding. B
and E show the transfer curves measured in different concentrations of GFP in 100 mM Tris
buffer. A shift to more positive potentials is visible in both cases with a stronger response in
the PEGylated case (B). C and F summarize the potential shift ∆V obtained as a function of
GFP concentration CGFSD in 1 mM (squares) and 100 mM (circles) ionic strength solutions.
∆V was read out at a constant ISD value, as indicated by horizontal lines in B and E. The
signal (voltage shift) in C is up to 3 × larger than that in F. Reprinted from.117 Copyrights
2017 Elsevier.
2.2.6 Control experiments with "off-receptor" and "off-target
To control for specificity of biosensor’s response, additional experiments (Fig. 2.6) were
conducted. As a control for the receptor specificity, the VHH was exchanged for bovine
serum albumin (BSA, "off-receptor", Fig. 2.6 A), unspecific for GFP maintaining the
same immobilization protocol, and measured in the same set of GFP concentrations in
100 mM buffer as the nanobody immobilized biosensors presented before. The transfer
curves are plotted in Fig. 2.6 B and the response vs. GFP concentration is shown in
Fig. 2.6 C. A small voltage shift of up to 5 mV due to unspecific GFP binding to the
biosensor’s surface is observed, which corresponds to approximately 20 % of the overall
signal obtained with VHH (Fig. 2.6 C). In the second experiment, we focused on receptor
specificity, where the VHH-modified biosensor was exposed to an "off-target" protein,
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tobacco etch virus protease (TEV, Fig. 2.6 D-F). TEV protease was chosen due to
similar molecular weight to GFP (M TEV = 29 kDa, M TEV = 27 kDa). In fact, similarly
low levels of non-specific adsorption were observed for TEV (around 5 mV). However, the
response trend was opposite to that of GFP (Figure 2.6 F). This is due to a difference
in charge of the two proteins. In the measurement buffer pH = 7.4, TEV is positively
charged (isoelectric point, IEP = 8.5 – 9.6), whereas GFP is negatively charged (IEP =
5.3 – 5.9). The transfer curves shift up to 8 mV to more negative potentials, which in
combination with the previous non-specific adsorption experiment allows the claim that
the VHH is indeed specific to GFP and the residual voltage shift is due to unspecific
binding of TEV to the surface itself. Based on these experiments, we conclude that most
of the signal presented in Fig. 2.5 C is due to specific interaction between VHH and GFP.
However, up to 20 % of the signal can be a result of non-specific interactions of the sensor
surface with proteins in solution (Fig. 2.6) and is a subject for further surface passivation.
Figure 2.6 – Non-specific adsorption experiments in 100 mM buffer with pH 7.4. A-C Non-
specific binding of target protein (GFP) to BSA-coated SWCNTs. B The transfer curves only
slightly shift to more positive voltages with increasing GFP concentration in 100 mM Tris
buffer. C The non-specific sensor response is much smaller than the specific binding shown
in Figure 2.3 C. The potential shift is positive because GFP is negatively charged at pH =
7.4 (IEPGFP = 5.3-5.9). D-F The selectivity of the VHH-coated sensor was tested using
TEV protease, a protein similar in size and molecular weight to GFP but with the opposite
net charge at pH = 7.4. E The curves shift only slightly to more negative voltages, indicating
good selectivity of the sensor. F The sensor response has the opposite sign compared to GFP,
because the isoelectric point of TEV is above the pH of the measurement buffer (IEPTEV =
8.5-9.6). Reprinted from.117 Copyrights 2017 Elsevier.
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2.2.7 Optimized SWCNT FET-based assay for GFP detection
The reduction of non-specific adsorption of the sensor was performed with 10 µM BSA
solution (Fig. 2.7A). After the surface passivation, the transfer curve was measured again
in blank Tris buffer (Fig. 2.7 B). To ensure surface passivation, the biosensor was ex-
posed to two control proteins with different isoelectric points: 100 nM BSA (IEP ∼4.8,151
close to the IEP of GFP ∼5.3-5.8) and 100 nM TEV (∼8.5-9.6). As seen in Fig. 2.7 C,
the voltage shift for non-specific adsorption of these 2 proteins (positively charged TEV
and negatively charged BSA) is nearly zero. Using this passivated biosensor, the specific
detection of even lower GFP concentrations ranging from 1 pM to 1µM was performed.
The maximum response is lower than shown in initial experiments without BSA blocking
(Fig. 2.5 C). The reduction of the signal comes from a significant decrease of non-specific
protein adsorption. Even for the lowest GFP concentration of 1 pM, the voltage shift is
well above the level of non-specific adsorption of 100 nM BSA and 100 nM TEV. The
biosensor reaches its maximum response ("saturates") at ∼100 nM (Figure 2.7 C). The
dynamic range of the biosensor spans from 1 pM to 100 nM (5 orders of magnitude) with
a possibility of further extension into the sub-pM regime. For comparison, a commer-
cial ELISA sandwich assay for GFP quantification152 has a measuring range of 3 orders
of magnitude (∼0.1 pM - ∼0.1 nM), is time-consuming (few hours) and requires multi-
ple washing steps. The additional blocking by BSA strongly suppresses the non-specific
adsorption below the detection limit, which is a significant improvement compared to
previously reported relatively high levels of non-specific adsorption (up to 30%6).
Figure 2.7 – Optimized SWCNT FET-based assay for GFP detection. A The PEGylated
sensor was additionally passivated with BSA to further reduce the non-specific adsorption. B
The transfer curves were measured in 100 mM buffer over a large range of GFP concentra-
tions. A shift of the transfer curve to more positive voltages is visible with increasing GFP
concentration (indicated by the arrow). C The sensor response ∆V vs. the concentration of
GFP on a log scale (squares). The dashed line represents the blank value (CGFP = 0). The
non-specific response to 100 nM TEV (circle) and BSA (diamond) is negligible. Reprinted
from.117 Copyrights 2017 Elsevier.
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2.2.8 CNT FET long-term stability
Next, the carbon nanotube field-effect transistors long-term stability is assessed. After
initial 0.5 h equilibration, the I-V curves (Fig. 2.8 A) scanned during the time frame of 96
hours do not exhibit significant shifts – a small drift of about -0.05 mV/h can be observed
(Fig. 2.8 B). This result confirms that the signal shifts in all experiments arise from the
binding events of different species to the surface of the nanotubes and are not a result of
signal drift in time.
Figure 2.8 – Long-term stability measurements. A Transfer curves in buffer after different
waiting times with an enlarged view in the inset. B The voltage at 1 µA is shown for 2
different devices. Almost linear drift is observed with the slope of -0.05 mV/h. This value
is lower (better) than for conventional Si devices, as shown in Tab. 2.1. Reprinted from.117
Copyrights 2017 Elsevier.
Table 2.1 – Long-term stability measurements comparison with silicon nanowires technology.
Reprinted from.117 Copyrights 2017 Elsevier.
this work fin FET153 HfO2 dielectric154 Al2O3 dielectric155
δV /δt / mV/h 0.05 0.1 1.88 0.3
Furthermore, an estimation of the dissociation constants (KD) of the GFP specific
VHH using Langmuir adsorption isotherm following the equation (Equation 2.3) is per-
formed:
∆V =
∆Vmax × C
KD + C
(2.3)
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where ∆V is the voltage shift in subthreshold region of the transfer curve, ∆Vmax is
the maximum voltage shift, KD is the dissociation constant and C is the concentration
of the analyte (GFP).
Table 2.2 – Comparison of dissociation constant values for VHH-GFP binding, obtained
with different sensor systems. The estimated KD values are consistent with previous reports
and our QCM data (see Fig. 2.4). Reprinted from.117 Copyrights 2017 Elsevier.
Transducer Sensor surface PEGylated KD Ref.
FET SWCNT yes + BSA blocking 0.08 ±0.06 this work
FET SWCNT yes 0.08 ±0.03 this work
FET SWCNT no 0.16 ±0.02 this work
QCM gold no 0.21 ±0.11 this work
QCM gold no 0.59 ±0.11 156
SPR gold no 0.32 157
SPR gold no 0.23 158
The estimated KD values for different surface modifications studied here are shown
in Tab. 2.2 and are in agreement with previous reports156–158 and the obtained QCM
data (Fig. 2.4). This further confirms the selective binding of GFP to the immobilized
nanobody receptors.
2.3 Discussion
In this work, I present a GFP-specific FET-based biosensor that employs high quality
sorted semiconducting SWCNT networks as the transducer and nanobodies as the recep-
tors. The polymer sorting process enables fabrication of highly uniform, homogeneous
and reproducible CNT FETs with high on/off ratios over 1000115,116,122 (see Fig. 2.1 B).
The approach used in this work is scalable and can be easily translated into printing
techniques, as shown recently by Rother et al.159 The CNT FETs are also proven to be
highly stable (the transfer curves shift only by 0.05 mV/h during long-term experiment,
see Fig. 2.8), which in comparison to the conventional silicon based devices is far more
stable (less drift observed, see Tab. 2.1).
As for receptors, it is the first time very short and stable nanobodies (VHH) are
employed in an FET setting. According to Ries et al.,160 the size of VHH specific to GFP
is merely ∼2 x 4 nm, whereas the epitope (binding site) is located on the longer edge of
the nanobody.14 The linker (pyrenebutyric acid, PBA) size can be estimated as a sum of
different bonds to be ∼0.7 nm (pi-pi stacking itself ∼350 pm,,161 4 × C-C bonds ∼150 pm
and 1 × C-O bond ∼ 180 pm162). Recently it has been shown by Hinnemo et al.37 that the
average thickness of a saturated self-assembled monolayer formed by using PBA solution
is 0.7 nm. Given that the large pyrene anchoring sites provide some spacing between the
receptor molecules as well as a 4-carbon aliphatic chain may allow some flexibility, I can
assume that the distance of linker and nanobody binding can be less than 0.7 nm. The
random orientation of VHH on the surface may be the reason that there is a small signal
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detected atributed to GFP adsorption even in high ionic strength buffer (100 mM), where
the Debye length is approximately 1 nm (Fig. 2.5 E, F).
This work provides an evidence that poly(ethylene glycol) co-immobilized with recep-
tor molecules on the surface of a FET biosensor enhances the overall specific signal of the
given biosensor. Here, I used 10 kDa PEG, which is about 76 to 10 nm150 long. Both
in low ionic strength (1 mM) and high ionic strength (100 mM) (see Fig. 2.5 A-C), a
substantial signal enhancement is recorded. In 100 mM buffer, a 3x signal increase is
achieved compared to no-PEGylated sensor. In low ionic strength buffer (1 mM), only
about 1.5 times signal enhancement is seen, most probably because the Debye length in
1 mM (10 nm) is long enough for the detectable charge to be almost 100%.150 The addi-
tional signal enhancement in 1 mM buffer is most likely due to a PEG molecules that are
stabilizing and properly spacing the immobilized biomolecules.163
The "PEG effect" i.e. signal enhancement in presence of PEG in high ionic strength
buffers is robust and reproducible, the exact mechanism of this phenomenon is still not
understood. The original papers by Gao et al.5,6 mention that PEG is responsible for
changing the dielectric properties of the interface. Haustein et al.150 discuss different pa-
rameters (capacitance, receptor density, dissociation constant of the receptor, and analyte
charge) that can influence the FET-based immunosensors by presence of a PEG layer and
conclude that the analyte charge is the only changing parameter. The analytical model
includes the assumption of the presence of Donnan potential, where the Debye screening
starts to occur not at the sensor surface (metal, oxide, CNTs etc.), but rather at the
surface layer (PEG)/electrolyte interface.
Compared to the original works on PEG-enabled specific detection of analyte by
FET biosensor in high ionic strength buffer,6 this work shows systematic concentration-
dependent studies with a wide dynamic range of analyte (GFP) determination (4 orders of
magnitude) with sub-picomolar lower limit of detection (LoD), and negligible non-specific
adsorption. Gao et al.6 presented the results only for relatively high PSA concentra-
tion ∼100 nM with rather high non-specific adsorption signals of up to 30 % and low
signal-to-noise ratio. Gutierrez et al.7 presented the gold extended-gate FET assay for
TSH determination using PEG for the same purpose - signal enhancement in high ionic
strength buffer. The authors used F(ab’)2 fragments and were able to determine thyroid-
stimulating hormone (TSH) concentration in horse serum (natively TSH free) from 0.5 to
10 000 pM, but observed only 17 mV maximum voltage shift for optimized assay condi-
tions (37 °C). In the case of CNT FET, a maximum voltage shift of 25 mV with <1 pM
limit of detection was observed in high ionic strength buffer in room temperature. Further
studies at elevated temperatures may increase the overall signal as well as decrease the
lower limit of detection of the assay.
In the past years, CNT FET based immunosensors have gained much attention (see
Tab. 2.3) showing high sensitivity and remarkably low detection limits (≤100 fM).54,164–166
Although, to best of my knowledge, those experiments were conducted in diluted buffer
or serum54,121,164,166–169 or even in the dry state.165,170,171 The challenge to overcome Debye
screening is valid for all the FET-based biosensors109 and limits the applicability of such
in e.g. Point-of-Care environment, where the time to result is crucial. This setting
requires simplicity and robustness, therefore sample dilution, low ionic strength washing
(or reading) buffers, or drying the sensor surface after the binding event, are not preferred.
The receptor length influence on the Debye screening problem in CNT FETs has been
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explored by Kim et al.54 The authors studied whole antibodies (∼10-12 nm), F(ab’)2
(∼5 nm) and Fab (∼3-5 nm) fragments and have found that the smaller the receptor,
the higher FET signal and lower the detection limit can be achieved. The presented
study has been performed in rather low ionic strength buffer (10 mM), where the Debye
length is expected to be ∼3 nm. In here, I present the direct detection of GFP in high
ionic strength solutions (Debye length <1 nm) using CNT FET in combination with even
shorter and more stable receptors - nanobodies.156 Although PEG is proven to reduce the
non-specific interactions,164,167,169 in this work, its main purpose is to enhance the FET
signal to enable immunosensing in physiological conditions5–7 as discussed above.
Table 2.3 – Comparison of different CNT FET biosensors that employed antibodies and
fragments thereof as receptors. Reprinted from.117 Copyrights 2017 Elsevier.
(* PEG used to reduce non-specific adsorption, § PEG used to enhance signal)
Receptor Analyte Dynamic range Sample Ref.
anti IL-6 IL-6 1.37 pg/ml-100 pg/ml(65 fM – 4.76 pM) diluted serum (1:100) in buffer
164
anti ARG 1 human ARG-1 30-100 ng/ml (0.857 – 2.857 nM) dry state 170
APQ4 loop peptide AQP4 antibody 1 ng/l - 1µg/l (28.57 fM – 28.57 pM) diluted serum (1:100 000) in buffer 166
p41 antibodies B. burgdorferi antigen (p41) 1 ng/l - 1µg/l (27.4 fM – 27.4 pM) dry state 165
whole antibody (10-12 nm) human IgG ∼1000 ng/ml (∼6.67 nM) 10 mM buffer 54
Fab’2 fragment (5-8 nm) human IgG 10 ng/ml-1000 ng/ml (66.7 pM – 6.67 nM) 10 mM buffer 54
Fab fragment (3-5 nm) human IgG 1 pg/ml-100 pg/ml (6.67 – 666.67 fM) 10 mM buffer 54
polymer+biotin streptavidin ∼2.5 µM 10 mM buffer 169 *
streptavidin IgG ∼100 nM 10 mM buffer 167 *
U1A protein 10E3 antibody 1 nM->30 nM 10 mM buffer 167 *
hemagglutinin anti-hemagglutinin 5 × 10-8 - 1 × 10-5 mg/ml (0.79 pM – 158.73 pM) dry state 171
anti-pig serum albumin pig serum albumin ∼2 µM 10 mM buffer 168
anti-PSA antibody prostate specific antigen <100 pM-100 nM 5 mM buffer 121
GFP specific nanobody GFP 1 pM – 10 nM 100 mM buffer this work §
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2.4 Conclusions
In this work, field effect transistors based on high-purity semiconducting carbon nan-
otube network were investigated as transducer, and in combination with short and stable
nanobodies as biological receptors, to produce a highly sensitive and stable biosensor. The
Debye length limitation (charge screening by ions in high ionic strength solutions) was
overcome by a mixed surface functionalization consisting of short receptors (nanobodies)
with poly(ethylene glycol) as a signal enhancer. This is the first time nanobodies were
applied in the FET-based biosensor setting. Immunosensing of GFP as a model anti-
gen was performed with the biosensor showing sensitive, selective and label-free protein
determination over a 4 orders of magnitude concentration range with a sub-picomolar
detection limit in high ionic strength (100 mM) solutions. Even without PEG, detectable
voltage shifts in high ionic strength solutions were recorded, only due to the presence of
nanobodies, which suggests that the small size and random orientation of VHH recep-
tors on the surface can enable analyte binding within the Debye length. The mechanism
of PEG-induced signal enhancement may be explained within the Donnan potential the-
ory,150 where the Debye screening starts to occur at the surface layer/electrolyte interface.
Further studies are needed to completely understand this effect. The estimated dissoci-
ation constant are not strongly affected by the presence of PEG and are in agreement
with previous reports for the GFP-nanobody binding. The presented CNT FET showed
long-term stability with very low drift of 0.05 mV/h, which is much lower than for con-
ventional silicon-based devices. The GFP determination range shown here is much wider
and significantly faster (<20 min vs. few hours) than for a commercially available ELISA
sandwich immunoassay. Finally, the presented direct nanoelectronic immunoassay is fast,
label-free, does not require any washing or sample dilution steps, and has the potential to
be used in Point-of-Care environment, where reliable results are needed within minutes.
3 | TSH immunosensing
with single-sheet graphene
field-effect transistor
The study described in this chapter was previously published as "Graphene-Based Elec-
tronic Immunosensor with Femtomolar Detection Limit in Whole Serum" in Advanced
Materials Technologies59 with Dr. Nesha M. Andoy as the first author and Marcin S.
Filipiak as the second author.
3.1 Introduction
Graphene, a two-dimensional material with a single-atom thickness, is extremely sensitive
in sensing molecules that interact with its surface,84,172 which makes it an attractive
transducer for (bio)sensing.173,174 In the field-effect transistor based biosensing, graphene
is widely used in so called "electrolyte-gated" configuration69,126,175–177 (for more details
see Section 1.2.2). Briefly, the receptor molecules (antibodies, aptamers etc.) are directly
immobilized on the surface of graphene serving as the channel in a field-effect transistor,
which is directly in contact with the liquid sample with the analyte. The gating occurs
through a reference electrode (e.g. Ag/AgCl) and the electric double layer forming in
electrolyte solution serves as the "dielectric" (in terms of classical MOSFET). Due to
highly sensitive charge transport in graphene, any electronic disturbance that can arise
from the binding event of a charged molecule to the surface of graphene, can lead to
drastic changes in the charge carriers transport (both holes and electrons).69,176,178 These
changes can be caused by different mechanisms: 1) electrostatic gating, 2) charge transfer
between the graphene and the analyte (acceptor or donor), 3) charge scattering across
graphene, 4) Schottky barrier effect or 5) capacitance modulation, often appearing as a
result of different effects at the same time.58,69,179,180
An interesting approach has been proposed by Gao et al.,5 where the authors co-
immobilize the receptor molecule with poly(ethylene glycol) on the sensor’s surface, en-
abling the protein immunosensing even in high-ionic strength solutions. Recently, Gutier-
rez et al.7 have shown that this strategy could be applied to thyroid stimulating hormone
(TSH) electronic immunoassay in whole serum, covering wide concentration range from
0.5 to 10 000 pM with ∼pM detection limit at 37 °C. The reference cutoff value for hy-
perthyroidism is <100 fM181 and thus a need for even lower detection limit of TSH with
FET-based biosensor is still unrealized, not to mention e.g. cancer and cardiac biomarkers
that require even lower limits of detection.182 Therefore, a new generation of higly-sensitive
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biosensing devices has to be developed to address the Point-of-Care application.183–185
Based on the concepts developed for CNT based biosensors, here, an electrolyte-gated
graphene field-effect transistor (GFET) was used as a transducer element to develop a
highly selective and sensitive TSH biosensor at room temperature with low-fM lower
limit of detection (LoD) in high ionic strength buffer. To do so, a mixed surface func-
tionalization has been employed: F(ab’)2 antibody fragments were co-immobilized with
poly(ethylene glycol). Commonly, the voltage shift in charge neutrality point of GFET
serves as the analytical signal and therefore, the analyte detection with GFET is said to be
caused by electrostatic gating effect. In this chapter, the precise analysis of multiple pa-
rameters of the analyte binding induced changes in graphene’s electronic response suggests
that the mechanism of analyte detection may be the scattering by charged impurities.
3.2 Results and discussion
3.2.1 Device fabrication
The fabrication of the GFET is described in more detail in Chapter 6. Briefly, the
GFETs were fabricated by the wet transfer of CVD grown Trivial Transfer Graphene
pieces floating on the surface of water to patterned gold coated glass chips (Fig. 3.1 A
and B). After the transfer, the graphene support layer - PMMA, was removed by acetone
using a Soxhlet extractor. The gold electrodes were used as source and drain contacts,
graphene as a channel of the FET and a bulk Ag/AgCl reference electrode (RE) as the
gate terminal. A PDMS slab with microfluidic channel was placed on the top of the
graphene coated glass chip to expose only graphene to the liquid in microfluidic channel.
Inlet and outlet tubes, as well as RE, were inserted into the PDMS slab as shown in the
Fig. 3.1 A. A representative Raman spectrum of the bare graphene on the glass substrate
is presented in the Fig. 3.1 C. A signature 2D band peak at 2684 cm−1 and G band at
1588 cm−1), the peak ratio (2D/G = 2.6) as well as the absence of defect peaks indicate
that the graphene sample is of high-quality and single-layer.74 The charge neutrality point
(CNP), V g,min, is shifted towards positive potential (V g,min = 120 ±60 mV (n = 20) Fig.
3.1 D), suggesting p-doping by the glass substrate and surrounding air.
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Figure 3.1 – Graphene FET measurement setup. A Microfluidic graphene FET glass chip
with single sheet graphene as FET channel, gold planar electrodes contacts and bulk Ag/AgCl
as RE. B Photograph of as manufactured graphene FET device C Raman spectrum of single-
sheet graphene showing characteristic peaks - 2D and G. D Reproducibility of charge neu-
trality point (CNP) of GFET in PBS buffer pH 7. Copyright 2018 by John Wiley & Sons,
Inc.
3.2.2 Surface functionalization of graphene
A schematic illustration of surface functionalization is shown in the 3.2 A. First, the sur-
face of graphene was functionalized using the mixed pyrene chemistry (i.e. 1-pyrenebutyric
acid : N -(1-pyrenyl)maleimide - molar ratio 10:1) by means of pi−pi stacking (see Section
1.1.3). PyMal was introduced in order to bind the 10 kDa thiolated poly(ethylene gly-
col) (PEG) - SH PEG OCH3 (see Section 1.1.3), while the PBA was used to introduce
-COOH groups that were later on used to aminocouple the antibody fragments (F(ab’)2)
using the EDC/NHS chemistry (see Section 1.1.3). As described in Chapter 2, the pres-
ence of PEG decreases the Debye screening, making the immunosensing in high ionic
strength solutions possible.6,7,60
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Figure 3.2 – Surface modification of graphene. A Scheme showing pyrene*-modified
graphene functionalized with thiol-PEG, then with the F(ab’)2 antibody fragment against thy-
roid stimulating hormone (TSH). Adapted from.59 Copyright 2018 by John Wiley & Sons,
Inc.
The transfer curves showing typical ambipolar behavior of graphene FET are presented
in the Fig. 3.3 A. The surface modification process can be monitored by the changes in the
transfer curves - PBA immobilization led to expected increased p-doping186 (Fig. 3.3 A-
inset and Fig. 3.3 B) with negligible changes on both hole and electron transconductance,
defined as the maximum slope of the both sides of the transfer curve gm = ∆I S/∆V G
(Fig. 3.3 C). For characterization purposes, PBA only was used (Fig. 3.3 A-inset), due
to maleimide groups easily hydrolyzing in aqueous solutions.187 Afterwards, thiol-PEG
was introduced which led to the shift of the transfer curve back to less positive CNP
voltages V g,min vs. PBA (Fig. 3.3 A & B). An appreciable asymmetric increase is seen
in both hole and electron transconductance (∆gm/gm−o), with electron transconductance
increase being more pronounced. These asymmetric changes in ∆gm/gm−o along with
shifts in V g,min are the main parameters that are subject to change upon analyte binding.
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Figure 3.3 – B Conductance Gs vs. gate voltage applied to the reference electrode VG before
and after surface functionalization (transfer curve). The gate potential at the minimum Gs
(Vg,min) for the bare graphene is indicated by the black arrow. Inset: Graphene’s transfer
curve before and after functionalization with pyrenebutyric acid (PBA). C Difference in
Vg,min (∆Vg,min) after various surface modification steps (relative to bare graphene). D
Relative changes in transconductance (∆gm/gm−o) of the hole and electron transport regions
after the same surface modification steps. Adapted from.59 Copyright 2018 by John Wiley &
Sons, Inc.
* pyrene = 10:1 1-pyrenebutytic acid (PBA):N-(1-pyrenyl)maleimide (PyMal).
After the PEG was immobilized, the -COOH groups from PBA coated graphene were
activated using the EDC/NHS chemistry (see Section 1.1.3 in order to aminocouple the
TSH specific F(ab’)2 antibody fragments (receptor molecules). F(ab’)2 immobilization
shifts the V g,min towards more positive potentials (p-doping) in comparison to PEG only
modified graphene surface (Fig. ?? B & Fig. ?? C). Additionally, an asymmetric decrease
in relative transconductance ∆gm/gm−o can be also observed, with a more pronounced
decrease for the electron part again (Fig. ?? D). Since TSH specific F(ab’)2 (IEP ∼ 7.5 -
8) is positively charged in PBS pH 7, when considering the electrostatic gating effect only,
the V g,min should shift to more negative potentials, while the transconductance should
not change.58,69,180,188 This points to the fact that the electrostatic gating mechanism is
not responsible for the change in transfer curves and therefore other mechanisms should
be taken into consideration (see Paragraph 3.1).
3.2.3 TSH detection in high ionic strength buffer
Specific TSH detection
The GFET-based F(ab’)2 modified biosensor was exposed to different TSH concentra-
tions in high ionic strength buffer (100 mM NaCl + 5 mM phosphate buffer pH 8). A
transfer curve shown in Fig. 3.4 A presents a representative graphene device measured in
buffer containing different TSH concentrations ranging from 10 fM to 10 nM with evident
changes around V g,min. With increasing TSH concentrations, the transfer curve shifts to
more negative potentials (n-doping of graphene). Taking ∆V g,min normalized to V g,min
measured in buffer, a calibration curve (logC vs. ∆V g,min) can be plotted (Fig. 3.4 B
(circle)), revealing that concentrations down to 10 fM are measurable and achieving a
dynamic range of >6 orders of magnitude (i.e., fM - nM). The calibration curve covers
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the reference values in serum sample coming from both healthy and unhealthy individuals
(≤100 fM - hyperthyroidism and >10 pM - hypothyroidism).181
Figure 3.4 – TSH detection in buffer: A Transfer curve of graphene after "F(ab‘)2 +
PEG" immobilization (dashed line) and after the addition of increasing concentration of
TSH (solid lines). B Vg,min shift after addition of 100 nM BSA (dotted line) and increasing
concentrations of TSH for two different surfaces (calibration curves): active "F(ab‘)2 +
PEG" (circles) and control "BSA + PEG" (squares). C The relative changes in electron
and hole transconductance (gm) with respect to the transconductance of F(ab‘)2 only (gm−o)
for the same surfaces as in B. This experiment was performed by Dr. Nesha M. Andoy.
Adapted from.59 Copyright 2018 by John Wiley & Sons, Inc.
The asymmetric relative transconductance changes in hole and electron transport upon
increasing TSH concentrations are shown in the Fig. 3.4 C (circles). A clear decrease in
∆gm/gm−o for electron transport (Fig. 3.4 C, half-filled circles) is seen, while no clear
changes were observed for the hole transport (Fig. 3.4 C, open circle). The said changes
however do not exceed ∼7% for electron transport even at 10 nM TSH. A TSH concentra-
tion dependent increase in the minimum conductance ∆Gm/Gm−o can be also seen in the
Fig. 3.4 A. From isoelectric focusing experiment, the isoelectric point of TSH (where the
net charge of the protein is 0) is ∼6.8, TSH is negatively charged at the experimental con-
ditions (pH = 8).189 Again, the apparent n-doping caused by TSH binding to the biosensor
as well as asymmetric changes in charge mobilities, cannot be explained by changes in the
carrier density due to electrostatic effects. This is in agreement with what was observed
after F(ab’)2 immobilization, and can further confirm that electrostatic effects are not the
dominating mechanism by which this graphene device senses analyte binding to F(ab’)2.
"Off-target" control experiment
The selectivity of the biosensor towards TSH was assessed by measuring the non-specific
adsorption of a well-characterized "off-target" protein, here bovine serum albumin (BSA),
which is known to bind unspecifically to graphene surface.190 Even for very high con-
centration (100 nM), the ∆V g,min recorded is ∼4× less than that from far lower TSH
concentration (10 fM) (Fig. 3.4 B, dotted line), showing that non-specific adsorption of
non-target proteins is much lower than the signal generated by receptor specific binding.
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"Off-receptor" control experiment
In order to make sure that the analytical signals (∆V g,min and ∆gm/gm−o shifts) are
truly originating from the antigen-antibody interaction, a control measurement with "off-
receptor" TSH-unspecific was performed. Here, F(ab’)2 was substituted with BSA and
co-immobilized with PEG on the graphene surface. Transfer curves obtained with in-
creasing TSH concentrations on an inactive "BSA + PEG" surface are presented in the
Fig. 3.6 A. No significant V g,min change for the control "BSA+PEG" surface is ob-
served with increasing TSH concentrations (Fig. 3.5B (squares)) in contrary to the active
"F(ab’)2+PEG" signal observed before in Fig. 3.4B (circles) - V g,min clearly shifts to-
wards more negative potentials. This confirms that V g,min can be used as an analytical
parameter for the determination of TSH, because it is only subject to change when the
specific antigen-antibody binding occurs.
Figure 3.5 – Transfer curves of GFET devices before and after TSH addition on control
surfaces: A "BSA + PEG" and (B) F(ab‘)2 only. TSH concentration dependent changes
in Vg,min C electron D and hole E transconductance obtained from the active "F(ab‘)2 +
PEG" (circle) and control: "BSA + PEG" (square) and F(ab‘)2 only (triangle) surfaces.
Adapted from.59 Copyright 2018 by John Wiley & Sons, Inc.
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Additionally, the non-specific TSH adsorption has an influence on the graphene elec-
tron and hole transconductance (∆gm/gm−o) as shown in Fig. 3.5C (squares). With
increasing TSH concentrations, the electron conductivity of the control surface slightly
decreases, similarly to the active surface, but less pronounced (Fig. 3.4 C, circles). When
it comes to the hole transport, with increasing TSH concentration, it increases as well,
which was not the case for the active surface (Fig. 3.4C), providing another distinction
between specific and non-specific interactions. Moreover, TSH concentration-dependent
changes in ∆Gmin/Gmin−o on the inactive surface can be seen, as the minimum conduc-
tance increases with increasing TSH concentration, similarly to the active surface (Fig.
3.6, squares). Consequently, the ∆Gmin/Gmin−o increase cannot be caused by specific
antigen-antibody interactions, but rather could be derived from non-specific interactions
of TSH with the graphene surface. Therefore, this ∆Gmin/Gmin−o cannot be used as an
indicator of measured TSH concentrations with GFET.
Figure 3.6 – Relative change in minimum conductance with increasing TSH concentration
for different surfaces: active surface "F(ab‘)2 + PEG" (circle), inactive surface "BSA +
PEG" (square), and F(ab‘)2 only (triangle). Adapted from.59 Copyright 2018 by John Wiley
& Sons, Inc.
The effect of PEG
The basic principle of FET-based (bio)sensors relies on the analyte’s charge detection,
which enables label-free detection of charged species. As already mentioned, charge
screening by high concentrations of ions present in solutions, pose a challenge (Debye
screening).191 The solution proposed earlier5–7,60 is based on co-immobilization of receptor
molecules and the poly(ethylene glycol), which was mechanically described by Haustein et
al.,150 enables the biodetection in physiological solutions. To verify this approach in this
work, a control measurements with "F(ab’)2 only" modified graphene and increasing con-
centrations of TSH were performed (transfer curves - Fig. 3.5 B) and compared with the
results obtained with "F(ab’)2 + PEG" modified graphene surface. The changes observed
with increasing TSH concentrations are shown in Fig. 3.5 C-E (triangle). The ∆V g,min
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for "F(ab’)2 only" surface decreases similarly to the additionally PEGylated biosensor,
but the magnitude of change is only 30% (at 10 nM TSH) of the signal obtained when
PEG is present (Fig. 3.4 A). Furthermore, the sensitivity (∆signal/∆concentration) of
the "F(ab’)2 only" biosensor (∆V g,min/∆C ) is much lower (from 10 fM to 10 nM ∆V g,min
shifts only -2.6 mV vs. -13 mV for "F(ab’)2 + PEG"). Moreover, asymmetric changes
in ∆gm/gm−o) for electron and hole transport can be observed – electron conductivity
increases significantly with increasing TSH concentration (Fig. 3.5 D) while hole conduc-
tivity does not change (Fig. 3.5 E). Finally, the minimum conductance ∆Gmin/Gmin−o
increases with increasing TSH concentrations, but less than the PEGylated biosensor (Fig.
3.6, triangle). An approximately 3-fold signal enhancement in the presence of PEG is in
agreement with previous reports on gold and carbon nanotube surfaces7,117 and is further
explained by Haustein et al.150 Briefly, the mechanism of PEG-induced signal enhance-
ment may be explained within the Donnan potential theory, where the Debye screening
starts to occur at the surface layer/electrolyte interface.
Interestingly, in comparison to the similar work of Gutierrez et al.7 with gold extended-
gate FET configuration using the same F(ab’)2 fragments and PEG as signal enhancement
strategy, the limit of detection (LoD) obtained with electrolyte-gated graphene FET is
much lower (<10 fM vs. 500 fM), which may be attributed to a different detection
mechanism.
3.2.4 Detection mechanism
Several parameters have been analyzed in the previous sections: 1) shift in charge neu-
trality point voltage V g,min, 2) change in minimum conductance of the transfer curve
∆Gmin/Gmin−o, and 3) hole and electron transconductance changes ∆gm/gm−o. Given
the results obtained with specific and non-specific detection of TSH on graphene FET, one
could deduct the biosensing mechanisms when using electrolyte-gated graphene field-effect
transistor based biosensor (see Paragraph 1.2.2). The most straightforward mechanism
for FET-based (bio)detection of charged (bio)molecules is the electrostatic gating effect.
Briefly, positively (+) charged (bio)molecules binding to the surface of the (bio)sensor in-
duce n-doping (shifting V g,min to more negatively potentials) and vice-versa, negatively (-)
charged (bio)molecules adsorption causes p-doping (shifting V g,min to more positive po-
tentials) without changing the transconductance.144,190,192–196 In this work, one can make
several observations: 1) negatively charged TSH (-) binding to the surface shifts V g,min
to more negative (-) potentials, positively charged (+) F(ab’)2 immobilization shifts the
V g,min to more positive (+) potentials. Furthermore, non-specific adsorption experiments
of a well-characterized BSA190,197 (IEP = 4.8, therefore negatively (-) charged in pH 8,
and positively (+) charged in pH 4) and TSH binding to the bare GFET surface were
performed (Fig. 3.7). The transfer curves for BSA (Fig. 3.7 A) and TSH (Fig. 3.7 C)
(both positively charged in pH 8) shift to the more negative potentials, whereas in pH
4, where both of the proteins are positively charged, the transfer curves shift to more
positive potentials (BSA - Fig. 3.6 B, TSH - Fig. 3.6 D). All of these observations do
not agree with the electrostatic gating effect as the detection mechanism, therefore it is
excluded from further consideration.
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Figure 3.7 – GFET electronic response towards non-specific detection of BSA and TSH at
pH 8 (A & C) and pH 4 (B & D). Adapted from.59 This experiment was performed by
Daniel Vetter. Copyright 2018 by John Wiley & Sons, Inc.
Direct charge transfer could be the reason for the shifts in V g,min, as previously shown
with detection of DNA and protein using a GFET.197–202 On the other hand, the asymmet-
ric changes in both hole and electron conductivity ∆Gmin/Gmin−o could not be explained
by that effect alone.70,172,198 The Schottky barrier effect (adsorption of the species on metal
contacts) cannot cause these characteristic asymmetric changes and the metal contacts
were well-passivated by placing the PDMS slab in a way that only graphene was inside
the microfluidic channel with tolerances of at least 500 microns, resulting in very low
leakage currents (Fig. 3.8). Therefore, one cannot expect any significant protein-induced
energy barrier modulation at the graphene/gold contact (semiconductor/metal Schottky
barrier).58
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Figure 3.8 – A Drain current (ISD) vs. gate current (IG). B IG as shown in A rescaled to
show that, compared to ISD, the gate current is at least 3-orders of magnitude lower C Con-
ductance of graphene as a function of gate voltage measured in different salt concentrations.
Adapted from.59 Copyright 2018 by John Wiley & Sons, Inc.
The conductivity of graphene σ for electron and holes is given by the equation:69
σ = µ× Cg × (Vg − Vg,min) (3.1)
where µ is charge carrier mobility, C g - gate capacitance, V g - gate voltage and V g,min
- minimum gate voltage.
From this equation it is evident that the charge carrier mobility µ and the gate ca-
pacitance C g can change the conductivity of graphene σ and thus the transconductance
(slope of the transfer curve). Upon protein adsorption one can see the transconductance
decrease, which can be caused by a capacitance decrease,203 since C g is proportional to
the permittivity of the interface. Generally, proteins and polymers have a lesser permit-
tivity than the electrolyte solution.6,58,204 Capacitance modulation cause the symmetric
slope changes in transfer curves6,58 and cannot explain the asymmetric changes in hole
and electron conductivity upon protein adsorption. Therefore, with the GFET biosensor
presented in this work, the observed changes in conductivity σ are not caused by the
capacitance change C g, but rather by changes in charge carrier mobility µ.
The mobility of holes and electrons in graphene can be a subject of change due to
scattering at charged impurities.70,125,205,206 It has been shown that with the increase of
ionic strength of the electrolyte solution, asymmetric changes in carrier mobilities and
a V g,min shift to more negative potentials occur.125,206 This phenomenon was explained
by Debye screening - the electrolyte ions can screen the effect of charged impurities (see
Section 1.2.2). Several transfer curves were recorded in different ionic strengths (from
1 mM to 1 M) and shown in the Fig. 3.8 C. The GFET exhibits asymmetric increase
in charge carrier mobility and a V g,min shift to more negative potentials, which implies
that the charge carriers are scattered on the charged impurities present on the surface of
graphene. Similarly, upon addition of PEG, a negative shift in V g,min and a significant
asymmetric increase in both hole (∼10%) and electron (∼25%) mobility occur (Fig. ?? B-
D). After F(ab’)2 immobilization and upon TSH binding, a similar asymmetric µ change
was observed. The electron transport decreased more compared to the hole transport upon
adsorption of those proteins, despite being oppositely charged under the experimental
conditions. However, their respective net charges determined the direction of the V g,min
shift.
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Table 3.1 – Detection mechanisms proposed for different Graphene-based FET devices.
Adapted from.59 Copyright 2018 by John Wiley & Sons, Inc.
Target analyte Biorecognition Molecule Proposed detection mechanism Type of graphene
ssDNA ssDNA electrostatic gating mechanical exfoliation192
CVD grown196
ssDNA ssDNA charge doping CVD grown198
CVD grown202
protein antibody electrostatic gating rGO193
mechanical exfoliation194
protein antibody & GPCR charge doping rGO197
CVD grown201
protein antibody charged-impurity scattering rGO209
rGO208
protein aptamer electrostatic gating mechanical exfoliation144
CVD grown195
protein aptamer charge doping CVD grown199
CVD grown200
protein aptamer charged-impurity scattering rGO208
Due to complexity of changes of the GFET electronic properties, it can be concluded
that more than one factor contribute to the characteristic transfer curve changes upon
analyte binding. Examples of devices using different biosensing mechanisms are listed
in the Tab. 3.1. It seems that for the same analyte (e.g. protein), different biosensing
mechanisms were proposed. This can be further explained by the differences in the de-
vice design and manufacturing, highlighting the importance of standardization of those
processes.207 For the GFET used in this work, the characteristic V g,min shifts and asym-
metric µ changes suggest that the major biosensing mechanism is most probably based on
modulation of charge scattering by charged impurities, similar to Kim et al. and Mansour
et al.208,209 However, it is not excluded that other biosensing mechanisms can take part
in the TSH detection with GFET and further work is needed.210 Overall, it is clear that
the presented TSH specific GFET-based biosensor can be used for quantitative determi-
nation of TSH in physiological solutions, which in future could be used for Point-of-Care
applications.
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3.3 Conclusions
Ionic screening of analyte charge has so far limited the use of FET-based biosensors
in physiological conditions. An electrolyte-gated graphene field-effect transistor-based
biosensor has been constructed by co-immobilizing poly(ethylene glycol) and TSH-specific
F(ab’)2 antibody fragments. The biosensor exhibited very high sensitivity of TSH deter-
mination ranging from fM to nM concentrations even in high ionic strength buffer. The
limit of detection (LoD) was estimated to be ∼10 fM. This is a significant improvement
of analytical parameters over previously published work by Gutierrez et al.7 using a gold
extended-gate FET configuration and similar surface modification. However, more focus
has to be devoted to the improvement of parameters like precision of immunosensing
and device-to-device variability, which can be addressed by establishing a more robust
and reproducible device (mass) fabrication process. Characteristic electronic response
of graphene (charge neutrality point voltage shift V g, change in minimum conductance
∆G/Go and the changes in hole and electron transconductances ∆gm/gm−o)) towards
analyte detection have been carefully examined. Using this approach, one can deduce
that the most probable biosensing mechanism for the presented TSH biosensing assay is
charge carrier scattering on surface impurities of graphene. Furthermore, the presented
GFET-based biosensor addresses the needs of Point-of-Care setting i.e. simplicity and
robustness (lack of sample pre-treatment, dilution or washing steps) as well as time to
result (<20 min).
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4 | Observation of direct electron
transfer from glucose dehydrogenase
to single-sheet graphene
The study described in this chapter will be submitted as "Observation of direct electron
transfer from glucose dehydrogenase to single sheet graphene electrode" to Electrochimica
Acta with Marcin S. Filipiak as first author.
4.1 Introduction
Diabetes is a group of metabolic disorders characterized by increased blood sugar or glu-
cose levels, which, if left untreated, can cause severe long-term complications. Therefore,
measuring glucose levels is important to ensure proper disease management for those di-
agnosed with diabetes. Glucose biosensors have been under development for more than
60 years since the first report by Clark and Lyons.1 In this so-called “first-generation”
glucose biosensor, the enzyme glucose oxidase (GOx) was employed, which with the help
of oxygen as an electron acceptor, was able to oxidize glucose. The glucose concentration
was measured indirectly either by measuring the decrease in local oxygen concentration
or increase in hydrogen peroxide concentration, a by-product of the enzymatic reaction.
The main principle, i.e. dependence on and correlation with oxygen concentration, was
at the same time a drawback, as the oxygen concentrations in a sample may vary leading
to false results. To overcome this issue, oxygen was substituted with an artificial elec-
tron acceptor, a mediator, that can be sensed at the electrode ("second generation"). An
example of a redox mediator for enzymatic determination of glucose is ferrocene, first
demonstrated in 1984.211 With a smart choice of mediator and the immobilization matrix
for the enzyme, researchers were able to lower the effect of interferences present in complex
samples (e.g. blood). The trend that has emerged over the last 30 years is to eliminate the
mediator and "wire" the enzymes’ active center to the electrode to transfer the electrons
directly ("third generation"). This phenomenon, called “direct electron transfer” (DET)
became a "Mount Everest" for (bio)electrochemists because it would enable studies of
direct enzyme-substrate interactions, not limited by the use of additional mediator, and
reduce the complexity of the system. DET could be highly advantageous for Continuous
Glucose Monitoring (CGM), since so far CGM is based on oxygen as means of cofactor
regeneration due to high requirements imposed on implantable devices (e.g. non-toxicity
excludes the use of mediators). The oxygen molar concentration in venous blood does not
exceed 0.2 mM211 and varies significantly with different conditions. Although there has
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been much research on DET in glucose biosensors, most researchers have used oxidases
that are oxygen sensitive. Unfortunately, it is difficult to distinguish the proposed DET
from the oxygen-mediated pathway, rendering some of the DET claims rather contentious
in the light of recent critical reports.212,213 To circumvent this issue, a possible solution
would be to use an oxygen insensitive enzyme such as glucose dehydrogenase, which has
been lately shown to facilitate DET.214 A recent review discusses direct electron transfer
of FAD-dependent dehydrogenase complexes, with a special interest in glucose dehydro-
genase (GDH).215 The applications of glucose dehydrogenase have been very limited so
far partly due to the enzyme’s substrate specificity issues.216 However, progress in en-
zyme engineering has led to highly specific GDH that, according to the manufacturer’s
specification sheet for the GDH used here,31 has sufficiently high specificity against other
sugars such as maltose, galactose and xylose.
Monolayer graphene has been shown to be suitable and advantageous for use in electro-
chemistry due to fast electron transfer kinetics.217,218 Quite recently, Kwak et al. proved
that it is possible to construct a flexible graphene-based enzymatic glucose sensor on PET
foil.216 On top of that, graphene offers the ability to easily pattern electrodes in differ-
ent shapes, including 3D structures and flexible substrates, that may be advantageous in
designing new biosensor configurations, e.g. for CGM devices.
So far, the term "graphene" in the context of electrochemical glucose biosensors claim-
ing DET has been used to describe different materials including e.g. reduced graphene
oxide,219 graphene oxide,220 nanosheets,221 nitrogen doped graphene,222 quantum dots,223
mesocellular graphene foam224 or simply flakes225 with a single exception of graphene
grown by chemical vapor deposition (CVD) and transferred onto a glassy carbon elec-
trode.226 For a comprehensive overview of research on DET with graphene and related
materials, see Tab. 4.1. Previous works have claimed that graphene may facilitate DET
by: 1) "plugging in" a carbon nanomaterial to access the active site, 2) partially unfold-
ing the protein (GOx) enabling the direct electron transfer to the electrode or simply 3)
having a high surface area with excellent conductivity.227
In this work, we used CVD grown single-layer graphene directly as the working elec-
trode (WE). The advantage of this material over frequently used (reduced) graphene oxide
is its high quality, resulting in higher conductivity, more control over surface modifica-
tion via non-covalent pyrene chemistry, and reduced probability of competing reactions
at defect sites. To study interactions between a single-sheet graphene and oxygen insensi-
tive glucose dehydrogenase, GDH was attached to graphene via short pyrene-based linker
molecules. Even though the use of glucose dehydrogenase in combination with graphene
was described before,228 this report was limited to the second generation glucose biosen-
sor (through mediated electron transfer). To the best of our knowledge, direct electron
transfer from GDH to graphene has not been observed yet. Due to the small linker size
(<1 nm), DET from the enzyme to the graphene electrode may be feasible.
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4.2 Results and discussion
A microfluidic PDMS channel with PTFE tubing was used to provide the solutions to
the electrochemical setup. A CVD-grown single layer graphene was used as a working
electrode, Ag/AgCl as reference electrode and a planar on-chip gold electrode was used
as a counter electrode (Fig. 4.1 A).
In Fig. 4.1 B, a schematic representation of redox reactions associated with electro-
chemical glucose biosensing for two different cases investigated in this work are presented.
Glucose oxidation catalyzed by glucose dehydrogenase involves two major redox steps: 1)
glucose oxidation coupled with reduction of flavin adenine dinucleotide (FAD) to its hy-
droquinone form – FADH225 and 2) active site regeneration by the final electron acceptor.
In this work, the regeneration was performed: 1) directly on the electrode (direct electron
transfer, DET) or 2) with a redox mediator (mediated electron transfer, MET) – in here
nitrosoaniline (NA).
When direct electron transfer is considered, the enzyme’s cofactor is regenerated di-
rectly by transferring an electron to the electrode when a suitable potential is applied (Fig.
4.1 A). In the case of the nitrosoaniline derivative (specifically N,N -bis(hydroxyethyl)-
3-methoxy-4-nitrosoaniline), the mediator must be first pre-activated by the enzymatic
oxidation of glucose in order to be sensed electrochemically (in other words - the first
glucose oxidation cycle, activates the mediator, which then can be used for further "cy-
cling"). In presence of glucose a nitrosoaniline derivative (Fig. 4.1 A - 1.) is reduced to
hydroxylamine in contact with the reduced form of the enzyme’s cofactor (2.). It hydrol-
yses homogenously to chinodiimine (3.), which then can undergo reduction with another
simultaneous oxidation of FADH2 to FAD present in the enzyme. The product of chin-
odiimine reduction – phenyldiamine (4.) can be electrooxidized on the electrode giving a
glucose dependent amperometric signal.
Figure 4.1 – A Microfluidic 3-electrode electrochemistry setup on glass substrate with single
sheet graphene as WE, gold planar electrodes as CE and bulk Ag/AgCl as RE. A PDMS
microfluidic channel was placed on top. B Reaction scheme of different glucose biosensing
pathways using glucose dehydrogenase described in this work. Path 1 is a direct electron
transfer (DET); Path 2 is mediated electron transfer (MET) with nitrosoaniline used as a
mediator.
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To construct a glucose specific biosensor, the graphene WE was modified with ap-
propriate glucose selective enzyme – in this work - flavin adenine dinucleotide, FAD-
dependent glucose dehydrogenase. First, the bare graphene was functionalized non-
covalently with a well-known pyrene derivative by means of pi-pi stacking36 which formed
a monolayer on the graphene surface (Fig. 4.2 A-B)). Here, 1-pyrenebutyric acid N -
hydroxysuccinimide ester (PBA-NHS) was chosen as a linker molecule (Fig. 4.2 B). The
acitvated linker was later used to couple the NH2 residues from surface lysines of glucose
dehydrogenase (Fig. 4.2 C). This resulted in a non-oriented covalent immobilization of
the enzyme on the linker-modified electrode. Raman spectroscopy is a valuable technique
to characterize a variety of parameters (doping, defects, strain, number of layers) of single
layer graphene.73,74 Raman characterization of untreated (Fig. 4.2 D, red), pyrenebutyric
acid (PBA)-functionalized (Fig. 4.2 E, blue) and GDH-PBA-functionalized (Fig. 4.2 F,
green) graphene films on glass substrates was performed. This spectroscopic technique
was used to probe the quality of the graphene film and confirm the molecular functional-
ization in conjunction with the presented electrochemical measurements. The untreated
graphene Raman spectrum (Fig. 4.2 D) depicts the prominent G mode peak of graphene
at 1589 cm−1. The low D-peak (≈1350 cm−1) intensity of the graphene film serves as a
quality indication of the film. After the PBA functionalization of graphene, the appear-
ance of Raman peaks associated (Fig. 4.2 E, blue spectrum) with a self-assembled layer of
PBA on graphene37 was observed. Following the GDH functionalization of PBA-treated
graphene films, an increase in the peak intensity of Raman peaks around ≈1520 cm−1
was observed (Fig. 4.2 F). The latter peak of a lower intensity is also present in the
PBA-treated sample.
Figure 4.2 – Surface functionalization and enzyme immobilization scheme - A bare graphene
electrode, B 1 mM 1-pyrenebutyric acid N-hydroxysuccinimide ester – PBA-NHS monolayer
C 1 mg/mL glucose dehydrogenase (GDH). Raman spectra of bare (D, red), PBA-NHS func-
tionalized (E, blue) and GDH functionalized (F, green) graphene film. Raman measurements
were performed by Kishan Thodkar (BioMed X GmbH).
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An increasing peak intensity (≈1520 cm−1) with increasing GDH concentration is
shown in Fig. 4.3 A. Furthermore, a consistent up-shift of one wavenumber in G peak
position in each step of functionalization with the PBA and GDH functionalization was
observed. This shift in the G peak position can be correlated with the change in the
charge carrier density of the graphene film (0.5 cm−1 ≈ 2.4x1011 cm−2).229 After the
functionalization, a charge carrier density change of ≈ 5x1011 cm−2 could be estimated.
Since the direction of the peak shift is towards higher wavenumber, our functionalization
process has a hole doping effect on the graphene film (see Fig. 4.3 B for further Raman
characterization).
Figure 4.3 – A Raman characterization of bare glass (magenta), graphene in air (red),
graphene in PBS solution (brown), PBA-NHS functionalized (blue), GDH functionalized (dif-
ferent concentration, green). B Raman spectra of G peak of bare graphene (red), PBA-NHS
functionalized (blue), GDH functionalized (green). Note the blue-shift of the peak position af-
ter each step of functionalization. Raman measurements were performed by Kishan Thodkar
(BioMed X GmbH).
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4.2.1 Direct electron transfer
While performing cyclic voltammetry measurements with graphene working electrode and
without any redox mediator, a pronounced glucose dependent signal as seen from Fig. 4.4
A was observed. To make sure that this oxidation current increase was caused by the
enzymatic reaction of glucose oxidation, a control experiment was performed, where the
graphene surface without the enzyme was exposed to different glucose concentrations and
cyclic voltammograms were recorded (see Fig. 4.4 B). The apparent oxidation current
decreases slightly with increasing glucose concentration, which may be due to the oxidation
of adsorbed species (contaminants) on the graphene surface. The calibration curves for
bare and GDH modified graphene electrode are plotted in Fig. 4.4 C. Since there is no
current increase without the enzyme, a conclusion can be made that the glucose dependent
current increase observed with the enzyme-coated graphene must be due to the enzymatic
activity, even though no redox mediator is present in solution. This behavior may be
explained by direct electron transfer (DET) from the active center to the electrode.
Figure 4.4 – Direct electron transfer from the cofactor of GDH on graphene/PBA-
NHS/GDH electrode. A Typical cyclic voltammetry curves of non-mediated enzymatic glu-
cose oxidation (10 mV/s, PBS pH 7). Inset: schematic representation of DET on graphene
coated with PBA-NHS and GDH. B Typical cyclic voltammetry curves of bare graphene
electrode in presence of different concentrations of glucose (10 mV/s, PBS pH 7). Inset:
schematic representation the bare graphene in contact with glucose solution. No DET oc-
cured in this case. C Calibration curves of glucose biosensing using direct electron transfer
on graphene/PBA-NHS/GDH electrode. A glucose concentration current increase is clearly
seen for GDH modified electrode, while for bare graphene electrode an insignificant current
decrease is seen.
To further investigate the DET pathway and to make sure that the pyrene linkers do
not contribute to the glucose oxidation, GDH-modified with pyrene-coated graphene was
compared. These experiments were performed in a PDMS well electrochemical cell format
to simplify the setup by removing active fluidics (see Chapter 6). Cyclic voltammograms
were recorded using PBA-NHS modified graphene electrode without (Fig. 4.5 A) and
with immobilized GDH (Fig. 4.5 B).
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Figure 4.5 – A Control experiment with graphene/PBA-NHS electrode showing no cur-
rent increase in presence of 100 mM glucose. B Enzymatic electrooxidation of glucose on
graphene/PBA-NHS/GDH modified electrode.
For the case of PBA-NHS functionalized graphene (Fig. 4.5 A), no current increase
was recorded upon addition of 100 mM glucose. For the case of GDH modified graphene
electrode (Fig. 4.5 B), an obvious oxidation current increase was seen when 100 mM
glucose was added. Furthermore, the voltammograms before and after glucose addition
match each other meaning that there is no glucose adsorption on the surface of GDH
modified graphene electrode. This control experiment confirms that the enzyme GDH is
responsible for glucose oxidation and not the pyrene linker molecules.
Next, chronoamperometric measurements were performed in a well setup (Fig. 4.6 A).
During a glucose measurement in blood, electrochemical interferences may occur and lead
to incorrect glucose values. Therefore, the influence of interferences must be carefully
considered when developing a glucose sensor. One of the most severe sources of inter-
ference in electrochemical blood glucose measurement is ascorbic acid (AA)230 with 0.08
mM upper limit of reference values in plasma.231 Without AA, a clear glucose dependent
signal was observed. With AA, there was significant ascorbic acid oxidation current. To
distinguish the current changes due to the glucose oxidation from the current coming from
the ascorbic acid oxidation, the background must be subtracted first. The following em-
pirical function was used to subtract the background: y = a− b× ln(x+ c) +d×x, where
y is the current and x is the time of the experiment. The chronoamperograms can be
seen on Fig. 4.6 A (before) and B (after subtraction). After subtracting the background
signal (AA oxidation current), it can be clearly seen (Fig. 4.6 B) that the currents due
to glucose addition are much smaller with AA than without. The calibration curves are
plotted in Fig. 4.6 C.
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Figure 4.6 – A A chronoamperometric response of the enzyme-coated graphene to different
glucose concentrations in PBS in absence (black) and in presence (red) of 0.2 mM ascorbic
acid (without mediator). B The chronoamperogram from A with the background current
subtracted. C Calibration curves in absence (black squares) and in presence (red circles) of
0.2 mM ascorbic acid after background subtraction.
The expected Michaelis-Menten behavior is observed with estimated KM = 68 mM
from fitting the data with the following equation (black line in Fig. 4.6 C): ∆j = (∆jmax×
Cglucose)/(KM + Cglucose), where ∆j is the absolute current increase, ∆jmax the maximal
absolute current increase, Cglucose the glucose concentration. The estimated KM exactly
matches the value provided by the producer of the enzyme (KM = 68 mM, BBI solutions),
confirming that the enzyme activity is fully preserved on the graphene surface.
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4.2.2 Mediated electron transfer using ferrocenemethanol as a
redox mediator
To test if the immobilization protocol preserved the activity of the enzyme, the con-
ventional ferrocenemethanol mediator was explored for glucose biosensing using cyclic
voltammetry. We performed several cyclic voltammetry experiments with increasing glu-
cose concentration using FAD-GDH modified graphene electrode. The voltammogram has
a shape typical of reversible one-electron redox reactions. The peak-to-peak separation is
∆E p = 121 mV and the formal redox potential is E °= 0.232 V vs. Ag/AgCl (3M KCl). For
a redox process involving one electron, the theoretical value of the peak-to-peak separation
should be 59 mV, which indicates that the resistance of the microfluidic electrochemical
cell is relatively high. As one can see in the Fig. 4.7 A, there is a ferrocenemethanol
oxidation peak increase with increasing glucose concentrations, while the reduction peak
of ferrocenemethanol is barely affected by the increasing concentration of glucose in the
solution. As one can see in the Fig. 4.7 B, a significant oxidation current increase was
observed for buffer containing ascorbic acid and ferrocene. In comparison with the buffer
without AA, the reduction peak of ferrocenemethanol was suppressed, and the oxidation
peak current is 3 times higher (w/o vs. w/ AA). On top of that, the curves’ peak currents
and potentials are not as predictable as the ones for the curves recorded without AA. To
make a calibration curve, the absolute current density increase (∆j ) was considered at
0.45 V (in diffusion-controlled regime of the electrooxidation reaction), which is defined
here as follows: ∆j = jglucose − jblank, where j glucose – oxidation current density for the
concentration of glucose, j blank – oxidation current density of ferrocenemethanol in buffer
without any glucose. The calibration curve is plotted in Fig. 4.7 C.
Figure 4.7 – Ferrocenemethanol as a conventional redox mediator in glucose biosensors. A
Typical cyclic voltammetry curves of FcMeOH mediated glucose oxidation, an increase in
glucose concentration increases the FcMeOH electrooxidation signal (scan rate: 10 mV/s,
solution: 0.1 mM FcMeOH in PBS pH 7) B Typical cyclic voltammetry curves of FcMeOH
mediated glucose oxidation in presence of 0.2 mM ascorbic acid. C Calibration curves of glu-
cose biosensing with FcMeOH with (red circles) and without (black squares) 0.2 mM ascor-
bic acid in solution. This set of measurements was performed by Daniel Vetter (BioMed X
GmbH.
The calibration curve for the case without AA presents a typical Michaelis-Menten
behavior, while for the case with AA the calibration curve is not predictable in a straight-
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forward manner. Additionally, the difference between the first concentration tested and
the “blank” is much higher indicating some additional chemical reactions in the system.
Using ferrocenemethanol as an electron mediator confirmed that the enzyme was suc-
cessfully immobilized and retained its activity on the surface. Upon exposure to a model
interferent – ascorbic acid, the performance of the biosensor to distinguish different con-
centration of glucose dropped significantly. The recorded voltammograms with ascorbic
acid showed that there is some interaction between ferrocene derivative and ascorbic acid
itself leading to unpredictable and high oxidation currents and lack of a reduction peak.
The catalytic behavior of ferrocene derivatives towards ascorbic acid oxidation is well-
known232 and shown in the Fig. 4.8.
Figure 4.8 – Cyclic voltammograms of a G/PBS-NHS/GDH in different solutions: PBS
pH 7 only (black), PBS pH 7 with addition of mediator 0.1 mM FcMeOH, PBS pH 7 with
addition of 0.2 mM ascorbic acid (orange), PBS pH 7 with addition of 0.2 mM ascorbic acid
and 0.1 mM FcMeOH.
Finally, using the Randles-Sevcik equation (see 1.11) and taking the voltammogram
recorded with bare graphene electrode (Fig. 4.9) one can calculate the electroactive
surface area to be A = 2.003 mm2, which is about 18% less than the estimated geometric
surface area. The difference may come from defects and impurities present on the surface
of graphene as well as the PDMS "self-passivation". The same electrode was also used to
confirm that the glucose itself is not electrooxidized on the surface of graphene.
Figure 4.9 – Cyclic voltammogram of bare graphene electrode in different glucose solutions
in PBS pH 7 with addition of 0.1 mM ferrocenemethanol.
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4.2.3 Mediated electron transfer using nitrosoaniline as a redox
mediator
To overcome the electrochemical interference limitations in glucose biosensing, a ni-
trosoaniline derivative (NA) was employed as a mediator, which is not affected by electro-
chemical interferents. Several cyclic voltammograms in pure PBS and in PBS with 10 mM
nitrosoaniline (Fig. 4.10 A) were recorded. Both CV measurements overlap confirming
that without the substrate (glucose) there is no redox signal increase. Afterwards, the
influence of ascorbic acid on nitrosoaniline oxidation (Fig. 4.10 B) was examined. With
AA only in solution, an ascorbic acid peak at ∼ 0.25 V vs. Ag/AgCl can be seen. When
NA is added, one can observe that the oxidation of ascorbic acid and nitrosoaniline add
up with no catalytic effects. Also, the ascorbic acid oxidation peak disappears in favor of
the overall shape determined by nitrosoaniline oxidation cyclic voltammogram.
Figure 4.10 – Nitrosoaniline electrochemistry on graphene. A Consecutive (1-5) cyclic
voltammograms of graphene/PBA-NHS-GDH electrode in PBS pH 7 and in 10 mM NA (10
mV/s) B Cyclic voltammograms of graphene/PBA-NHS-GDH in pure PBS pH 7 (black), 10
mM NA (blue), 0.2 mM AA (orange) and 10 mM NA + 0.2 mM AA (red) in PBS pH 7.
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Next, several cyclic voltammetry experiments with increasing glucose concentration
using graphene/PBA-NHS-GDH electrode in presence of nitrosoaniline (Fig. 4.11 A)
were performed. There are no clearly developed oxidation peaks, yet an overall oxidation
current increase with increasing glucose concentrations is seen. For the case with AA
(Fig. 4.11 B), one can see a very similar trend of current increase offset by ∼ 3 µA/cm2.
The calibration curve of glucose concentration vs. absolute current increase (readout at
E = 0.45 V) was plotted in Fig. 4.11 C and the results obtained for the case with and
without AA match each other.
Figure 4.11 – Nitrosoaniline as a redox mediator in glucose biosensors. A Typical cyclic
voltammetry curves of NA mediated glucose oxidation (10 mV/s, 10 mM NA in PBS pH 7)
B Typical cyclic voltammetry curves of NA mediated glucose oxidation in presence of 0.2 mM
ascorbic acid. 10 mV/s, 10 mM NA in PBS pH 7 C Calibration curves of glucose biosensing
with NA with and without 0.2 mM ascorbic acid in solution.
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4.2.4 Discussion
Here, an enzymatic electrode consisting of a single-layer graphene functionalized with
glucose dehydrogenase was used for glucose determination. We evaluated different path-
ways of glucose enzymatic oxidation on graphene electrodes: 1) based on direct elec-
tron transfer (DET) and 2) based on mediated electron transfer (MET) using the rel-
atively unexplored nitrosoaniline (NA) derivative (N,N -bis(hydroxyethyl)-3-methoxy-4-
nitrosoaniline). Compared to conventional mediators such as ferrocenemethanol, which
was explored in the Section 4.2.2 (Fig. 4.7, 4.8 and 4.9), nitrosoaniline is much less
affected by cross-reactivity with interferents. On the other hand, ferrocenemethanol is
readily available to act as an electron mediator and produces more electrochemical signal,
whereas nitrosoaniline must be pre-activated first, which is done enzymatically and thus
limited by enzyme turnover. The limiting step of the NA reaction mechanism seems to be
the enzymatic activation of nitrosoaniline to chinodiimine - the electrooxidation reaction
rate is higher than the enzymatic activation, which is confirmed by the lack of oxidation
peaks of phenyldiimine. As a result, there are no "background" redox peaks as in the case
of ferrocenemethanol, which means that any recorded current increase will be associated
with glucose oxidation.
Regarding the DET pathway, a recent editorial in Biosensors and Bioelectronics dis-
cussed the inability of native glucose oxidase, a similar simple flavoprotein, to undergo
direct electron transfer.213 The most explored, yet unconvincing evidence for it is based on
direct electrochemistry of FAD/FADH2 pair about -450 mV vs. Ag/AgCl. These charac-
teristic peaks were also observed by Vogt233 with redox titrations showing that the formal
potential for free FAD at pH 7.4 is -0.417 V vs. Ag/AgCl and -0.302 V vs. Ag/AgCl for
the bound (expected when considering DET). In a recent critical article212 the authors ar-
gue that most studies claiming direct electron transfer on nanostructured electrodes were
not carried out carefully and conscientiously. Appropriate control measurements were not
always performed, and the only evidence provided by many researchers was the presence
of peaks around -450 mV. However, their source was not necessarily the glucose oxidase
itself. With a series of simple experiments with attaching free flavin or catalase, Bartlett
and Al-Lolage mimic the “Holy Grail” FAD/FADH2 peaks and conclude that the men-
tioned redox peaks come from the contaminants of glucose oxidase. If non-deoxygenated
buffers were used and voltammograms recorded in the range where one could expect
FAD/FADH2 peaks,213 it cannot be excluded that the glucose detection mechanism in a
vast majority of the articles claiming DET on graphene may be based on O2 depletion,
rather than on DET (for the comprehensive list of articles where this may be the case,
see Tab. 4.1). This would classify these reported devices as “first generation” rather than
“third generation” glucose biosensors. Therefore, it was postulated,213 that there is a need
to develop new enzymes, in particular dehydrogenases, since they are oxygen independent.
Unfortunately, so far, the use of glucose dehydrogenases has been limited mainly due to
specificity issues, yet this has been overcome with recent advances in FAD-GDH protein
engineering.25 The GDH enzyme used here is highly specific for glucose, as mentioned in
the introduction.
The direct electron transfer at a distance above 1.7 nm is unmeasurably small.265 In
a native glucose oxidase, the active center – FAD/FADH2 is buried deeper than 1.7 nm,
therefore a DET is very unlikely to be measured. Interestingly, in a recent publication,266
researchers demonstrated that DET is possible with FAD-dependent glucose dehydroge-
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Table 4.1 – Articles claiming direct electron transfer on graphene modified electrodes.
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nase. This phenomenon is explained by the following mechanism: the FAD-GDH can
transfer the electrons by means of intramolecular charge transfer from the cofactor - FAD
via iron-sulfur cluster in the catalytic subunit (3Fe-4s) to hemes in the electron trans-
fer subunit and from these directly to the electrode (the exact mechanism is described
elsewhere267).
Here, a graphene electrode and pyrenebutyric acid as a monolayer for aminocoupling
the enzyme, was used. The average thickness of a saturated monolayer formed by using
PBA solution was measured to be 0.7 nm and the orientation of the PBA towards the
graphene surface is concentration dependent.37 Since in our experiments we used only
1 mM PBA (non-saturated monolayer), PBA is most probably "lying flat" on graphene,
with the pyrene functional group parallel to the graphene surface, whereas in the saturated
monolayer case, the PBA would bind at a higher angle close to 90° with respect to the
graphene surface. Therefore, the maximum linker length is well below 0.7 nm, which is
within the relevant range for DET to occur.
Control measurements with different surfaces were performed: bare graphene (Fig.
4.4 B) and PBA-NHS modified graphene (Fig. 4.5 A) and no oxidation current increase
in response to glucose addition was observed. This provides further evidence for non-
mediated or direct electron transfer in the studied monolayer system. With respect to
electrochemical interferences in the DET pathway, the glucose oxidation currents are
lowered when ascorbic acid is added to the solution. At this point, one can only speculate
on the exact nature of the interactions between the electrode surface and the ascorbic acid.
However, these interfering contributions may be reduced if AA can be excluded from the
vicinity of the electrode surface by appropriate surface modification, for example, by
adding polyethylene glycol.
Comparing the glucose dependent oxidation currents for the case of MET and DET
(Fig. 4.4 vs. Fig. 4.11), one can clearly see that the MET currents are substantially
higher (5x). This effect can be easily explained by the orientation of GDH on the surface
of the electrode. Here, the enzyme’s immobilization is random and generally one can dis-
tinguish two different types of orientations: 1) when the active center is directed towards
the electrode enabling the DET and 2) all other orientations, where DET is suppressed
due to long distance. Statistically, one can assume that this preferred DET-enabling ori-
entation is less probable and some of the enzyme molecules are not directly connected
to the electrode, but can remain catalytically active when a redox mediator is provided.
Therefore, more enzyme molecules contribute to the MET glucose signals than to DET.
To increase the DET currents, oriented enzyme immobilization may be envisioned which
would require additional enzyme engineering to introduce specific binding sites.268
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4.3 Conclusions
In summary, high-quality large-area CVD grown single-layer graphene was investigated
as a working electrode for the enzymatic detection of glucose. The electrode was modified
with a monolayer of FAD-dependent glucose dehydrogenase and different paths (direct vs.
mediated) of electron transfer were studied. A glucose-dependent increase of oxidation
current was measured even in the absence of redox mediators, indicating that direct
electron transfer may occur in this monolayer system owing to the short linkers used. To
corroborate these results, additional control measurements were performed with bare and
with linker modified graphene and no significant glucose dependent signals were recorded.
To the best of my knowledge, this is the first time that a direct electron transfer from
an oxygen insensitive glucose dehydrogenase to a monolayer graphene electrode surface
has been reported. Previous works employed glucose oxidase instead, which is highly
sensitive to oxygen, raising concerns about the robustness of DET observations to date as
oxygen dependency or impurities may be misinterpreted as DET signals. To reduce the
interfering signals, a novel redox mediator was used – a nitrosoaniline derivative (N,N -
bis(hydroxyethyl)-3-methoxy-4-nitrosoaniline). It is only activated in presence of glucose
and interference effects can be easily subtracted. This is the first time a nitrosoaniline
derivative was employed as a mediator on a GDH-coated single layer graphene electrode.
While the measured DET currents are smaller than those in the mediated cases, the
probability of DET may be further increased by site-specific enzyme immobilization. Also,
the surface may be passivated by polymers such as polyethylene glycol to exclude ascorbic
acid and other electrochemical interferents from the vicinity of the electrode. Overall,
the presented monolayer-based DET device may have certain advantages, for example, in
continuous glucose monitoring (CGM), where the use of diffusional mediators is prohibited
due to toxicity or limited long-term stability. On the other hand, the use of nitrosoaniline
is justified in "regular", i.e. single-use, glucose test strips, because it helps to easily
eliminate the effects of electrochemical interferences.
5 | Conclusions and outlook
”One never notices what has been done;
„Człowiek nigdy nie ogląda się na to, co zrobione,
one can only see what remains to be done”.
ale na to patrzy, co ma przed sobą do zrobienia”.
— Maria Skłodowska-Curie
This work presented multimodal detection (electrochemical and electronic) of biomolecules
with biosensors based on different carbon nanomaterials (carbon nanotubes and graphene).
Semiconducting carbon nanotube networks are shown to make good transistors and in-
terestingly, can be ink-jet printed as shown recently by Rother et al.159 Graphene, on
the other hand is still troublesome for mass-manufacturing, yet it seems that it is more
susceptible to electrical characteristics change, which can be both advantageous (lower
limit-of-detection, higher sensitivity of the biosensor), as well as problematic (more cum-
bersome analysis of adsorption of species). An attempt of elucidating the biosensing
mechanism of GFET was made. For the presented assay, the TSH detection mechanism
most likely relies on charge carrier scattering on surface impurities of graphene. For other
analytes, it may be different though, therefore careful analysis of the GFET behaviour
is needed. The device-to-device variaton is lower in case of CNT FET than for GFETs,
so more work has to be dedicated to develop reproducible manufacturing processes of
GFETs. Both transistor setups presented in Chapter 2 and Chapter 3, significantly re-
duce the problem of Debye screening in high ionic strength (physiological) buffers through
the addition of a PEG layer. It is not excluded though, that there are different polymers
to subsitute poly(ethylene glycol).
The next steps for the assays presented here will be measurements in more complex
media like e.g. blood (Andoy et al. worked with serum59). Despite different PEG immo-
bilization methods, the "PEG effect" i.e. signal enhancement, with respect to the mono
SAM (PBA), was about ∼3-fold. More laboratory work as well as theoretical modelling
has to be dedicated to understand the mechanisms of PEG-induced signal enhancement.
In this work, either GFP-specific nanobodies or TSH-specific F(ab’)2 was used as
model receptors, but in future, one cannot exclude the use of different receptors, including
whole antibodies (most probably different PEG lengths and linker-to-PEG ratios would
be needed), aptamers or even molecularly imprinted polymers. Additionally, oriented
immobilization of receptors on the surface to bring the binding sites closer to the surface
of the transducer could be advantageous for generating overall higher analytical signals.
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Furthermore, here, pyrene derivatives were used as linkers for both receptor immo-
bilization and PEG functionalization. Other, non-pyrene linkers based on pi-pi stacking
could be used to enhance the density of the monolayers on the surface of graphene or
carbon nanotubes.
Interestingly, a comparison of different processes of graphene FETmanufacturing could
be made. Reduced graphene oxide platelets network, non-PMMA based transfer of CVD
graphene (e.g. with paraffin shown to be result in less residues on the surface of graphene)
could be compared. Moreover, a "flip-over" transfer of CVD graphene can be assessed,
where as CVD grown graphene on copper foil is flipped over and attached to the substrate
surface (e.g. with a polymer) and then the copper layer is etched away leaving a clean,
non-polymer polluted graphene surface.
Interestingly, it was demonstrated that the exactly same graphene electrode/transistor
setup can be employed in electrochemical biosensing (as a working electrode) and in
electronic (as an electrolyte-gated field-effect transistor’s channel). Future studies will
focus on detection of the same analyte with those two different techniques with the hope
that the analytical parameters (dynamic range, lower limit of detection, sensitivity) of
the multimodal approach will be enhanced.
It was also recently shown that semiconducting carbon nanotubes can be advantageous
for facilitating direct electron transfer from glucose dehydrogenase.269 A setup used in
Chapter 2 can be beneficial for making a DET-based electrochemical biosensor due to
high surface area and the three dimensional structure of the nanotube network.
Additionally, one could envision the use of graphene and/or carbon nanotube FET
based transducer for creating a platform (in e.g. 96 well plate format) and immobilize
the target of interest at the surface of carbon nanomaterial based FETs in order to screen
synthetic libraries of nanobodies to select the nanobodies with the highest binding affini-
ties.
As an interesting alternative, multiparameter analysis of a single liquid sample could
be also taken into consideration. By mass production of multielectrode/multichannel
chips and controlled surface modification (either by means of selective (electro)chemistry,
spotting of the biologicals/chemicals or simply by introducing a physical barrier between
devices on one chip), one could construct a biosensor platform that is able to monitor
more than one quasi-specific analyte (parameter) at a time to make the biosensors output
specific. This would help to diagnose complex diseases like e.g. sepsis, where different
biomarkers are involved, but there is so far no single specific biomarker to diagnose it.
Obviously, if glucose sensing with glucose dehydrogenase was possible, other enzymes
for crucial metabolites could be employed (e.g. lactate).
Finally, from the materials science point-of-view, it would be interesting to test a
device (working electrode, EGFET channel) comprising of both carbon nanotubes and
graphene combined as means for higher surface area, which could benefit both readout
methods.
6 | Materials and methods
6.1 Single-walled carbon nanotube network field-effect
transistor for immunodetection in physiological con-
ditions
Methods described here refer to the study described in the Chapter 2.
6.1.1 Preparation of SWCNT dispersions.
SWCNT purification was carried out by Marcel Rother (Uni Heidelberg).
Plasma torch SWCNTs (RN-220, 0.9 - 1.9 nm of diameter, 0.3 – 4 µm of length,
SWCNT content 60 - 70%, 70% semiconducting SWCNTs, produced by NanoIntegris,
Inc.) are added to 2 mg/mL toluene solution of PF12 (poly(9,9-di-n-dodecyl-fluorenyl-
2,7-diyl)) to achieve 1.5 mg/mL RN-220 content and bath sonicated for 90 minutes. Next,
the dispersion is centrifuged for 45 mins at 60 000 g to remove undispersed material. The
supernatant is collected and centrifuged again at 268 000 g for 60 minutes to remove SWC-
NTs bundles. The supernatant is transferred to a fresh centrifuge tube and centrifuged
at 268 000 g for 16 h to remove excess polymer. After the solvent is removed, the formed
pellet was washed with THF and stored dry until redispersed in pure toluene again just
before the alignment step.
6.1.2 FET fabrication
FET fabrication was performed by Marcel Rother (Uni Heidelberg).
Interdigitated bottom electrodes (channel width 2 mm, channel length 20 µm) are pat-
terned by means of photolithography using double layer photoresist (MicroChem LOR5B
and Microposit S1813) and evaporated with an electron-beam evaporator (Ti/Au thick-
ness 2+30 nm). After that, 1 mL of the redispersed SWCNTs is placed on top of the
electrodes and an AC voltage is applied (80 V, 0.1 Hz). Substrates are then washed
with THF to remove residual polymer. Atomic force microscopy (tapping mode, Bruker
Dimension Icon) is used to determine the average SWNT density: 5-6 µm−1. Gold con-
tacts are passivated in another photolithography step using SU-8 2005 (diluted 1:1 with
cyclopentanone resulting in a thickness of approx. 1 µm) to reduce leakage current.
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6.1.3 Liquid handling
The liquid cell is made from a polydimethylsiloxane (PDMS, Dow Chemicals) slab, cast
from a CNC milled Teflon mold with defined microfluidic channels. Inlet and outlet
PTFE tubing is introduced as well as a Ag/AgCl reference electrode (DRIREF-2, World
Precision Instruments). The liquid cell is aligned on the chip and pressed down with a
cover. Liquids are introduced into the channel using a Harvard PhD Ultra syringe pump
in withdrawal mode (25 µL/min, if not stated otherwise).
6.1.4 Expression of receptor and analyte molecules
Expression of receptor and analyte molecules was performed by Christopher Bachran
(BioMed X GmbH).
VHH GFP enhancer (a camelid heavy chain VHH fragment specific to green fluores-
cent protein and additionally enhancing its fluorescence),156 enhanced GFP (eGFP) and
tobacco etch virus protease (TEV) are expressed recombinantly in E. coli. VHH GFP en-
hancer gene in plasmid pHEN (kindly provided by H. Ploegh, Whitehead Institute, MIT,
USA) is transformed into E. coli strain WK6 for expression. eGFP is cloned into plasmid
pET19b (Novagen) using NcoI and EcoRI sites. TEV (maltose binding protein fusion
to TEV containing a S219V point mutation, MBP-TEV S219V, kindly provided by D.
Waugh via Addgene, plasmid reference RK793) and eGFP plasmids are transformed into
E. coli strain Rosetta (DE3) pLysS (Novagen). For all three proteins, protein expression is
induced by 1 mM Isopropyl-β-D-thiogalactoside at an OD 600 nm of 0.8-1 for 3 h at 37 °C
in a shaker. Cultures are centrifuged (4000 × g, 15 min, 4 °C), resuspended in phosphate-
buffered saline (PBS) and sonicated (2 × 1 min at 100 % intensity and 0.5 second duty
cycle on a Sonopuls HD2070 (Bandelin) equipped with a MS 73 microtip). Samples are
centrifuged (4000 × g, 15 min, 4 °C), supernatants applied to Ni-NTA Agarose-loaded
columns (Macherey & Nagel), washed by 20 and 50 mM imidazole in PBS before elution
in 250 mM imidazole in PBS. Eluted samples are concentrated in Amicon centrifugal filter
devices with 3 kDa and 10 kDa cut-off for VHH GFP enh and eGFP / TEV, respectively
(Millipore). Concentrates are dialyzed over night against PBS before concentrations were
determined by A 280 nm measurements.
6.1.5 Surface functionalization
An ethanol solution of 1 mM 1-pyrenebutyric acid (PBA, Sigma-Aldrich) and 0.25 mM
mPEG-pyrene (molecular weight = 10 kDa, Creative PEGWorks) to achieve heteroge-
neous SAM (“mixed SAM”) or just 1 mM PBA to get homogeneous SAM (“mono SAM”),
is continuously introduced into the microfluidic channel for 1 h. After that, the chan-
nel is briefly washed with ethanol and deionized water and then kept in 100 mM Tris
buffer pH 7.4 (Carl Roth). Then, after a brief flush with deionized water, 100 mM N-
hydroxysuccinimide (NHS) and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC,
both Sigma-Aldrich) aqueous solution is pumped into the channel for 20 minutes to ac-
tivate the surface. After that, either a 10 µM GFP-specific nanobody VHH or 10 µM
bovine serum albumin (BSA, Carl Roth), in 0.2 M phosphate buffer (pH 7) is introduced
for 1 h for specific and non-specific adsorption experiments, respectively. Finally, in case
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of optimized SWCNT FET based GFP sensing assay, the surface is blocked with BSA
(Carl Roth).
6.1.6 Measurement setup
A microfluidic PDMS channel with PTFE tubing is used to provide the solutions to
the transducer. A bulk Ag/AgCl reference electrode is inserted in the middle of the
microfluidic channel to control the gate potential. Typical current-voltage curves can
be seen in Fig. 2.1 C. A constant bias voltage VSD = 100 mV is applied between the
source and drain gold electrodes and the gate voltage VAg/AgCl is swept from -750 mV
to 750 mV. The measurements are repeated three times, if not stated otherwise. All
FET measurements are recorded using a dual-channel source meter (Keithley 2636 B) in
Tris buffers at ambient temperature of 21±2°C. All measurements are performed after 30
minutes initial stabilization time.
6.1.7 QCM study
A quartz crystal microbalance system (Q-Sense E4, Biolin Scientific AB, Stockholm, Swe-
den) is used to test the immobilization protocol for VHH nanobodies and to measure the
binding of the green fluorescent protein (GFP). Prior to immobilization, the gold-coated
QCM chips are first cleaned in UV/ozone for 10 min and hot base piranha (= 5:1:1 mix-
ture of ammonia : H2O2 : water) at 75 °C for 5 min, rinsed with deionized water, dried
with nitrogen and cleaned in UV/ozone again for 10 min. After cleaning, the chips are
immersed in a 1 mM 6-mercaptohexanoic acid solution in a 3:1 ethanol : water mixture
at 37 °C overnight to assemble a monolayer with functional COOH groups. After rinsing
with ethanol and water and drying with nitrogen, the QCM chambers are assembled and
the chips primed with buffer (10 mM, pH 7.4) to reach a stable baseline, continuously
monitored by QCM. The surface is then activated with 100 mM EDC and 100 mM NHS in
H2O for 20 min, followed by a short rinsing in buffer (1 min) and incubation in anti-GFP
VHH antibody solution in buffer for 30 min. Then, the surface is rinsed with buffer again
to remove unbound VHH, and is subsequently incubated in 100 nM GFP solution.
6.2 TSH immunosensing with single-sheet graphene field-
effect transistor
Methods described here refer to the study described in the Chapter 3.
6.2.1 Materials
CVD-grown graphene (Trivial Transfer Graphene; lateral size 5 cm × 5 cm) is pur-
chased from ACS Material (Pasadena, CA). The F(ab‘)2 fragment of an anti-TSH an-
tibody and the recombinant TSH antigen are kindly provided by Roche Diagnostics
GmbH (Penzberg, Germany). PDMS (SYLGARD-184) for flow chamber fabrication was
from Dow Corning (Midland, MI). Polyethylene glycol (mPEG-SH, Mw = 10 kDa) is
from Nanocs, Inc. (Boston, MA) and the linker PEG (SH-PEG-COOH, Mw = 460 Da)
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from Celares GmbH (Berlin, Germany). PBA, PyMal, and horse serum are from Sigma-
Aldrich (Steinheim, Germany). 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC),
N -hydroxysuccinimide (NHS) and all the other chemicals are from Carl Roth (Karlsruhe,
Germany) unless otherwise stated.
6.2.2 Fabrication of substrate and gold contacts
Glass slides (25 × 25 mm) are first sonicated with acetone, isopropanol, and deionized
water for 15 min. After drying in N2 they were then oxygen plasma cleaned for 5 min.
After that, titanium (10 nm) and gold (100 nm) are thermally evaporated using a shadow
mask to achieve desired pattern (Fig. ??). The resulting glass substrate is then kept dry
at room temperature until use. Immediately prior to graphene transfer, the glass substrate
is first cleaned by sonication in deionized water for 10 min then N2 dried. Afterward, base
piranha (1:1:5 of NH4OH:H2O2:H2O volume ratio) cleaning is done for 20 min at 80 °C.
After thorough rinsing with deionized water and drying with N2, the glass substrate is
then treated further with O2 plasma for 5 min then kept in water, ready for graphene
transfer.
6.2.3 Graphene transfer and flow chamber assembly
The PMMA-coated single-layer graphene sheet is transferred following instructions from
ACS Material. The graphene is manually cut and transferred between the empty space
of two gold electrodes (∼3 × 3 mm). The excess water is air dried for at least 30 min,
making sure graphene dries on top of the gold contacts. The air-dried slides are then
baked on the hot plate at 120 °C for 20 min. To remove the PMMA layer, the glass
slides are washed with acetone for 24 h using a Soxhlet extractor. With this method, the
samples are always flushed with a freshly condensed acetone making the cleaning more
effective. After acetone cleaning, they are baked on the hot plate at 120 °C for 20 min
to remove residual organic solvents. Each chip containing two graphene devices is then
used or stored at room temperature until further use (Fig. ?? C). The flow chamber
is then assembled by placing the PDMS chamber and sealing with the printed circuit
board (PCB) for connection with the source and drain contacts. Polytetrafluoroethylene
(PTFE) tubing is used to flow solution in and out of the chamber using a syringe pump
(Harvard Apparatus, Holliston, MA), ensuring a rapid exchange of liquids within the
active channel.
6.2.4 Surface functionalization and TSH detection
After the flow cell is assembled the bare graphene surface is washed with dry ethanol for
10 min. The surface is then modified with pyrene-based compounds to anchor both the
F(ab‘)2 receptor and PEG to the surface of graphene. First, 1 mM PBA + 0.1 mM PyMal
in dry ethanol is flowed into the chamber and incubated for 60 min to functionalize the
graphene surface with 10:1 PBA:PyMal. After incubation, the unbound pyrene is washed
with dry ethanol for 10 min at 100 L/min. The solution within the chamber is then
exchanged to aqueous for PEG immobilization by flushing with water then PBS (150 mM
NaCl + 50 mM phosphate buffer pH 7), for 1 min each. 200 M solution of thiolated-
mPEG (SH-mPEG, Mw = 10 kDa) in PBS is then added to immobilize PEG polymer on
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maleimide-functionalized pyrene. The PEG solution is incubated for 2 h before washing
with PBS. The PBA is then activated with 100 mM EDC + 100 mM NHS for 20 min
before 0.3 mg/mL F(ab’)2 is added to the chamber. F(ab’)2 solution is then incubated
overnight at 4 °C then washed with PBS to remove non-immobilized F(ab‘)2.
6.2.5 Measurement setup
FET characterization is performed before and after addition of increasing concentration of
TSH both in 50 mM phosphate buffer pH 8 + 150 mM NaCl. Electrical measurements are
performed using a dual-channel source meter (Keithley 2636B) at a constant source–drain
voltage V sd = 100 mV the gate potential V g is swept typically from -0.5 to 0.5 V. An
Ag/AgCl reference electrode (WPI, Dri-REF, customized length) is placed near the sensor
surface (through the PDMS chamber) to control the gate potential.
6.3 Observation of direct electron transfer from glucose
dehydrogenase to graphene
Methods described here refer to the study described in the Chapter 4.
6.3.1 Single-sheet graphene electrodes
Glass substrates (25 x 25 x 1.1 mm, Borofloat 33) are bought from Schott, Germany and
thoroughly sonicated for 15 minutes in acetone, isopropanol (Carl Roth, Germany) and
deionized water, subsequently. After drying with N2 stream, they are put into O2 plasma
cleaner for 10 minutes. Next, a metal shadow mask was used to evaporate a pattern of
10 nm titanium and 100 nm gold. After hydrophilizing the surface with another 5-minute
plasma treatment, Trivial Transfer Graphene pieces from ACS Material, LLC (USA) are
"fished" from the surface of water onto the glass substrates. The graphene with PMMA
on top is left to air dry and then baked on a hot plate for 20 minutes in 80 °C. To remove
the PMMA, the samples are put into Soxhlet apparatus overnight, which enabled cycled
rinsing with freshly distilled acetone. Next, the samples are rinsed with isopropanol and
baked for 20 minutes in 80 °C to evaporate leftover solvents.
6.3.2 Liquid handling
The liquid cell is made from polydimethylsiloxane (PDMS, Dow Chemicals) slab, casted
out of Teflon mold with defined microfluidic channels. Inlet and outlet PTFE tubing
and Ag/AgCl reference electrode (DRIREF-2, World Precision Instruments) are inserted
into PDMS slab. The liquid cell is aligned on the chip in a way the contact electrodes
for graphene are outside the fluidic channel and pressed with a cover. The liquids are
introduced into the channel using a Harvard PhD Ultra syringe pump.
6.3.3 Surface functionalization
An ethanol solution of 1 mM 1-pyrenebutyric succinimide acid (PBA-NHS, Sigma-Aldrich)
is introduced into the microfluidic channel for 1 h. After that, the microfluidic channel
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is briefly washed with ethanol, deionized water and PBS buffer (150 mM NaCl + 50
mM Na2HPO4, pH 7.4, Carl Roth). After that, 1 mg/mL of FAD-dependent GDH (BBI
Solutions, UK) in PBS (pH 7.4) is introduced for 1 h.
6.3.4 Measurement setup
A microfluidic PDMS channel with PTFE tubing is used to provide the solutions to the
electrochemical setup. A CVD-grown single layer graphene is used as a working electrode,
Ag/AgCl as reference electrode and a planar on-chip gold electrode is used as a counter
electrode. In well setup experiments, a PDMS slab with a through hole is placed on
the glass chip forming an open well, where bulk RE and a Pt wire are placed. The
geometric surface area of exposed graphene is estimated to be 2.44 mm2 and the currents
are recalculated to current density using this value. The electrochemically active surface
area is estimated to be ∼ 2.00 mm2 (see Subsection 4.2.2 4.9). Cyclic voltammetry
experiments ware typically performed from 0.0 to 0.5 V with 10 mV/s scan rate. For
chronoamperometry measurements, 0.3 V is applied continuously and currents for the
background (600 s) and upon glucose stock solution recorded (for 300 seconds each). All
the measurements are recorded using an Ivium-n-Stat multichannel potentiostat (Ivium
Technologies) in PBS pH 7.4 at ambient temperature of 21 ±2 °C.
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List of abbreviations:
• AC - alternating current
• BSA - bovine serum albumin
• CE - counter (auxiliary) electrode
• CNT - carbon nanotubes
• CVD - chemical vapour deposition
• DNA - deoxyribonucleic acid
• EC - Enzyme Commision
• EDC - 1-ethyl-3-(-3-dimethylaminopropyl) carbodiimide hydrochloride
• EGFET - electrolyte-gated field-effect transistor
• ELISA - enzyme-linked immunosorbent assay
• F(ab’)2 - antibody fragment with two antigen-binding sites linked by disulfide bond
• Fab - antibody fragment with one antigen-binding site
• FAD - flavin adenine dinucleotide
• Fc - ferrocene
• FET - field-effect transistor
• GDH - glucose dehydrogenase
• GFET - graphene field-effect transistor
• GFP - green fluorescent protein
• GO - graphene oxide
• GOx - glucose oxidase
• IEP - isoelectric point
• IgG - immunoglobulin, antibody
• IHP - inner Helmholtz plane
• kcat - turnover number
• koff - off-rate constant
• kon - on-rate constant
• Ka - association (binding) constant
110 BIBLIOGRAPHY
• Kd - dissociation constant
• KM - Michaelis-Menten constant
• LoD - limit of detection
• MW - molecular weight
• MAL - maleimide group
• MOSFET - metal-oxide-semiconductor field-effect transistor
• mPEG-pyrene - poly(ethylene glycol) modified with pyrene functional group
• NA - nitrosoaniline derivative, specificallyN,N -bis(hydroxyethyl)-3-methoxy-4-nitrosoaniline
• NHS - N -hydroxysuccinimide
• NT - nanotube
• OHP - outer Helmholtz plane
• PBA - 1-pyrenebutyric acid
• PBA-NHS - 1-pyrenebutyric acid Nhydroxysuccinimide ester
• PEG - poly(ethylene glycol)
• PMMA - poly(methyl methacrylate)
• PoC - Point-of-Care
• py-MAL - N -(1-pyrenyl)maleimide
• QCM - quartz crystal microbalance
• RBM - radial breathing mode
• RE - reference electrode
• rGO - reduced graphene oxide
• STM - scanning tunelling microscopy
• SWCNT - single-walled carbon nanotubes
• TEM - transmission electron microscopy
• TEV - tobacco etch virus protease
• TSH - thyroid stimulating hormone
• VHH - nanobodies
• WE - working electrode
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List of symbols:
• λD - Debye length
• νF - Fermi velocity
• ρe - local electric charge density in C/m3
• ε - dielectric constant (relative permittivity) of the solvent
• ε0 - permittivity of vacuum
• Ψs - potential across the EDL
• D - diffusion coefficient
• E - electrochemical potential
• e - elementary charge of electron (1.602 × 1019)
• E - standard electrode potential
• F - Faraday constant ( 96 485 C / mol)
• gm - transconductance
• I - current
• ISD - source-drain current
• kB - Boltzmann constant
• kcat - turnover number
• KM - Michaelis-Menten constant
• L - FET channel length
• NA - Avogadro constant (6.022 × 1023 mol−1)
• Q - charge density in the channel
• R - universal gas constant (8.314 J / mol K)
• T - temperature in Kelvin
• t - time in seconds
• VG - gate voltage
• VSD - source-drain voltage
• Vth - threshold voltage
• W - FET channel width
• z - charge of the ion
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